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ABSTRACT 
 RNA helicases are vital components of various pathways for post-transcriptional 
gene regulation. TgHoDI is a newly identified member of the DEAD-box RNA helicase 
family in Toxoplasma gondii. This study was aimed at characterizing the function of 
TgHoDI in post-transcriptional regulation during various stages of the parasite life cycle. 
Through immunofluorescence analyses, TgHoDI was found to colocalize with mRNA 
aggregates in cytoplasmic foci. Furthermore, colocalization studies of TgHoDI with 
PABPC3 identified these proteins as components of RNA aggregates known as stress 
granules. Cycloheximide and arsenite treatment of extracellular parasites revealed the 
presence of mechanisms involved in the determination of mRNA fate in Toxoplasma. 
Also, TgHoDI was found to functionally compliment the temperature sensitive phenotype 
in Δdhh1 yeast, validating its role in stress response. These findings confirm that TgHoDI 
is a vital component in the formation of stress granules and possibly involved in the 
mechanisms of post-transcriptional gene regulation. 
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CHAPTER I - LITERATURE REVIEW 
1.1 Toxoplasma gondii as a model organism  
  Toxoplasma gondii is an intracellular parasitic protozoan and serves as a model 
organism for the study of pathogenic Apicomplexa members including Plasmodium, 
Neospora, Eimeria and Cryptosporidium [1]. In comparison to other Apicomplexa, T. 
gondii is easily propagated in vitro using cell monolayers. Also, a high transfection 
efficiency and the ability to stably express protein epitope tags allows for the study of 
biochemical properties that are not readily expressed in other organisms. The haploid 
nuclear genome which contains 14 chromosomes, consisting of approximately 8 x 10
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base pairs [1], allows for the modification or elimination of genes through mutagenesis 
without allelic complementation. Thorough documentation of mutagenesis and selectable 
markers allow for the isolation of transformed parasites in gene replacement studies 
through homologous and random recombination [2]. In addition, the well-established 
mouse model and the ability to monitor host response has made T. gondii ideal for the 
study of Apicomplexan biology. 
1.2 Life cycle  
 Toxoplasma is unique in its capability of infecting and replicating in virtually any 
nucleated avian or mammalian cell [3]. The parasite's life cycle consists of two parts; 
sexual reproduction within the feline (definitive host) and asexual replication correlating 
with non-feline infections (intermediate host) [4]. Due to its implication in human 
disease, the asexual life cycle will be discussed in further detail. The asexual life cycle 
consists of two distinct stages known as tachyzoite (tz) and bradyzoite (bz), which result 
in acute or chronic infections, respectively [4]. In the acute tachyzoite stage, parasites are 
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in a rapid growth form and are capable of active infection. Tachyzoites enter the host cell 
by penetrating through the host cell membrane and become surrounded by a 
parasitophorous vacuole (PV). Parasite replication within host cells occurs at a generation 
time of 6 to 8 hours within the PV through the process of endodyogeny [3]. Endodyogeny 
is a form of indefinite reproduction in which two progeny form within the parental 
parasite [5]. The production of a large number of parasites, approximately 64-128, leads 
to the rupture of host cells (lysis). Parasites then exit the cell, in a process referred to as 
egress, and are then able to infect neighbouring cells [3]. Under the stress of the host's 
immunity, tachyzoite to bradyzoite differentiation occurs, resulting in the formation of 
tissue cysts approximately 7-10 days post-infection [4]. This marks the second asexual 
stage, which is characterized by slow parasitic growth. Similarly to tachyzoites, 
bradyzoite parasites divide by endodyogeny, resulting in increased cyst size [4]. These 
cysts are found primarily in muscle tissue and the central nervous system, where they 
remain for the entirety of the host's life [3].  
1.3 Clonal Lineages of T. gondii 
 Toxoplasma consists of three clonal lineages, type I (RH and GT-1), II (ME49) 
and III (CEP and VEG), which differ in virulence and epidemiological occurrence [6]. 
Although the strains are divided amongst these three clonal groups, at any given locus the 
three groups only possess two separate alleles, which are ~98% identical at the nucleotide 
level [7]. All three strains share the trait of oral infectivity thereby bypassing the need for 
the sexual stage of the parasitic life cycle [8]. This bypassing of sexual reproduction, as 
well as the need of a definitive host, limits genetic recombination and hinders the 
formation of a wider range of genotypes [9]. Furthermore, infection in intermediate hosts 
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is typically caused by a single strain and therefore recombinant genotypes are unlikely to 
emerge [8].  
 Studies by Sibley and Boothroyd (1992) sought to determine the variation in 
parasitic strains by means of polymerase chain reaction (PCR) and restriction fragment 
length polymorphisms (RFLPs) [10]. In the study, 28 isolates from a diverse set of hosts 
were analyzed using a subset of gene probes previously used as characteristic markers for 
the genetic and physical mapping of the Toxoplasma genome. An example of such a 
marker, surface antigen-1 (SAG1), is a single-copy gene encoding the major surface 
antigen [10]. RFLP analysis revealed that all three strains showed an identical RFLP 
pattern for the genes studied, indicating the genetic homogeneity among the strains [10]. 
Consistent with this, the differences among the strains, at the genome sequence level, was 
determined to be less than 1% [10]. Similar studies conducted by Howe and Sibley 
(1995), which performed PCR/RFLP studies on 6 independent loci, determined that the 
percentage of nucleotide divergence between estimated strains was <5% [11]. 
Furthermore, studies by Cristina et al. (1995) resulted in comparative results when 
performing RFLP and isoenzyme analysis on 14 parasite isolates [12]. This genetic 
homogeneity has lead to the conclusion that these virulent strains, I, II and III, were 
recently derived from a single clonal lineage [13].  
 The studies conducted provided preliminary analysis of Toxoplasma genome, 
which has since been fully sequenced by the J. Craig Venter Institute. The completion of 
the parasitic genome subsequently lead to the assembly of the bioinformatic database 
referred to as ToxoDB [14]. This database is a culmination of studies conducted by 
several researchers in the field to provide access to the genomic sequence of all known T. 
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gondii strains [15]. Furthermore, the database contains annotation of the type II strain 
with analyses of express sequence tags (ESTs), single nucleotide polymorphisms (SNPs) 
analyses, open reading frames (ORFs) identification, proteomic and microarray studies 
[15]. Due to the highly similar genomes of the three clonal strains, data exhibited for the 
type II strain provides an accurate representation of information on the remaining two 
strains. 
 Although there is no significant variation at the genomic level, studies in mice 
have shown that infections by the various clonal lineages result in altered pathogenesis; 
with type I strains being highly virulent in comparison to the relatively non virulent type 
II and III strains [10]. This enhanced virulence of type I is in part due to the over-
activation of the Th1 immune response, which is a cell-mediated immunity targeting 
intracellular pathogens [8]. Furthermore, type I strains share a combination of alleles at 
many loci, which is not seen in non-virulent strains, indicating acute virulence is a result 
of genotype variations [8]. Analysis of T. gondii strains in human disease has found an 
increased frequency of type I stains in AIDS patients, however the majority of infections 
are caused by type II strains [16]. Furthermore, type I has been associated with recurrent 
ocular toxoplasmosis in immunocompromised patients, suggesting that type I is more 
pathogenic [17]. Taken together however, most studies in North America and Europe has 
identified type II strains as the most prevalent cause of human toxoplasmosis in 
congenital and AIDS patients while type III is largely confined to animals [18, 19]. 
1.4 Pathogenesis  
 T. gondii is the causative agent of toxoplasmosis which effects a third of the 
human population [6]. Infection can generally occur by ingestion of contaminated meat, 
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water or the exposure to oocysts present in infected feces. During an acute acquired 
infection, individuals exhibit influenza-like symptoms with limited cases of prolonged 
fever, lymphadenopathy or retinochoroiditis [1]. As a result, clinical manifestations are 
commonly limited to immunodeficient individuals such as AIDS patients. Among these 
individuals, intracerebral focal lesions may result in encephalitis, that if left untreated, 
can be fatal. Congenital toxoplasmosis may also occur and is a result of an acute infection 
of an expectant mother. The ability of tachyzoite parasites to be transmitted through the 
placenta, as well as the lack of a fetal immune system, causes infection in the unborn 
fetus [6]. The severity of congenital infection varies; however, spontaneous abortions and 
neurological disorders, such as toxoplasmic encephalitis and ocular toxoplasmosis may 
occur [6]. The current drug therapy for toxoplasmosis consists of a drug regimen centered 
around pyrimethamine in addition to either sulfonamides or clindamycin [1]. The 
combination of clindamycin and pyrimethamine is used in patients with who do not 
tolerate sulfonamides [20]. These drugs effectively kill parasites in the tachyzoite stage, 
however do not target the chronic bradyzoite stage [1]. This, combined with the toxic side 
effects of these drugs, creates the need for a more effective and long-term clinical 
treatment. Due to the prevalence of Toxoplasma infection in the human population, it is 
necessary to understand the developmental mechanisms behind stress response, primarily 
those involved in parasite differentiation and cyst formation. Analysis of gene expression 
and regulation which accompanies such cellular processes may allow for the 
understanding of the underlying mechanisms responsible and assist in the determination 
of better clinical treatments.  
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1.5 Gene Regulation 
 Throughout the parasitic life cycle, a fine balance of transcriptional and 
translational control occurs to maintain proper levels of gene expression. Gene regulation 
is fundamental for the coordinate synthesis, assembly and localization of macromolecular 
structures of the cell, thereby ensuring proper functioning of biological mechanisms 
necessary for survival [21]. Gene regulation can generally be divided into two levels: (i) 
transcriptional and (ii) post-transcriptional regulation.  
(i)Transcriptional regulation ensures that the levels of transcripts are maintained at the 
necessary levels throughout various growth and developmental stages. For transcription 
to occur, certain regions of chromosomes (genomic DNA) must first be made accessible 
to allow for the binding of the transcription protein complex. The accessibility of DNA is 
altered by a class of chromatin remodeling enzymes, for example those capable of 
covalently modifying histones. The genome of Toxoplasma contains several histone 
acetyltransferases which were determined to be necessary in the transcriptional regulation 
of chromatin bound to histone 3 (H3) and histone 4 (H4) [1]. The acetylation of lysine 
residues on the N-terminal histone tails results in the transcriptional activation and 
repression by the addition or removal of acetyl groups, respectively [22]. Similarly, the 
addition of methyl groups to lysine and arginine residues on H3 and H4 has been shown 
to confer gene activation and silencing in Toxoplasma, with five protein 
methyltransferases and a lysine-specific demethyltransferase homologue identified [1]. 
Furthermore, several putative proteins were identified in the genome of Toxoplasma 
whose eukaryotic homologues act in histone modification by means of activation, 
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through phosphorylation, ADP-ribosylation, and ubiquitylation, or repression, by means 
of sumoylation [1, 23].  
  Studies by Soldati and Boothroyd (1995) demonstrated that genomic regions 
flanking ORFs, referred to as cis-elements, were able to confer both characteristic 
specificity and strength of expression of endogenous protein coding regions [24]. These 
elements identified in the 5'-flanking region vary in size from a hundred to thousands of 
nucleotides and have been exploited in the construction of expression vectors, resulting in 
the high expression of target genomic sequences [24]. Examples of these 5' exploited 
promoter regions are the tachyzoite-specific expression vectors derived from lactate 
dehydrogenase 1 (LDH1) or surface antigen 1 (SAG1) and bradyzoite-specific vectors 
constructed from bradyzoite antigen 1 (BAG1) or enolase 1 (ENO1). Although specific 
cis-acting elements in the 5'-flanking regions of many genes have been identified, such as 
the six tandemly repeated 27 base pair repeats directing transcription initiation of SAG1, 
the exact location of regulatory elements of many genes remains unknown [1]. 
 The coupling of these cis-elements with sequence-specific DNA binding proteins, 
known as trans-regulating factors, have been shown to control gene regulation of target 
sequences. This is carried out by the binding of these factors to specific sequences 
resulting in the promotion or repression of transcription by the activation or inhibition of 
RNA polymerase, respectively [22]. These factors are classified on the basis of their 
DNA binding domains which may consist of: (i) a helix-turn-helix, (ii) two cysteine-two 
histidine zinc finger, (iii) a multi-cysteine zinc finger or the (iv) basic DNA binding 
domain [25]. Stimulation of transcription results from the assembly of the basal complex, 
which consists of RNA polymerase II and transcription factors such as transcription 
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factor IIB (TFIIB), at specific activation domains present in the promoter of a gene [25]. 
In comparison, inhibition of transcription by protein factors may function in several 
mechanisms including: (i) the binding of an inhibitory factor which directly represses a 
gene, (ii) binding of a factor which interferes with the binding of stimulatory factors or 
(iii) the quenching of stimulatory factors by binding of inhibitory units [25]. In 
Apicomplexa, the presence of trans-regulating factors, such as TFIID, and the emergence 
of proteins containing nucleotide binding domains within the parasitic genome suggesting 
to the presence of such transcriptional regulation mechanisms in these organisms [1]. 
Studies by Vaquero et al. (2005) confirmed the action of such trans-regulating factors in 
P. falciparum in which a DNA binding protein, PfMyb1, was determined to be involved 
in a regulatory network of proteins required for parasite growth [26].  
(ii) Post-transcriptional regulation is required for the completion of mRNA synthesis 
and occurs prior to export of transcripts from the nucleus. Three major processes which 
comprise the post-transcriptional alterations of pre-mRNA within the nucleus are the (i) 
acquisition of a 5' cap structure, (ii) splicing out of introns and (iii) addition of a poly(A) 
tail. After the synthesis of approximately 30 nucleotides, the addition of the 5' cap 
structure occurs in a series of steps [27]. First, the pre-mRNA 5'-triphosphate is 
hydrolyzed to a diphosphate by an RNA triphosphatase. Then, guanylyltransferase 
catalyzes the addition of a GMP molecule to the recently hydrolyzed nucleotide residing 
on the 5' end of the pre-mRNA. In the final step of the reaction, a methyltransferase 
methylates the N7 position of the GMP, completing the cap structure [27]. Interestingly, 
both the RNA triphosphatase and the guanylyltransferase remain attached to the mRNA 
and act to recruit the cap binding complex (CBC) [27]. The CBC is believed to function 
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in the stabilization of mRNA by hindering the ability of 5'-3' exonucleases to access the 
mRNA. 
 The next processing event in eukaryotes is the splicing of non-coding sequences 
known as introns. Within the pre-mRNA several consensus cis-elements are present 
which are necessary for the splicing reaction. These elements are the 5' and 3' exon-intron 
junctions (indicated by |) which are marked by the consensus sequences of AG|GURAGU 
and YAG|RNNN (R: purine, Y: pyrimidine), respectively [27]. Furthermore, a 
branchpoint is present approximately 100 nucleotides upstream of the 3' exon-intron 
junction which contains a highly conserved adenosine [27]. Splicing occurs in two 
distinct steps and is catalyzed by the spliceosome which is comprised of five small 
nuclear RNAs assembled with other proteins [27]. These components are essential in the 
assembly, stabilization and activity of the spliceosome complex, resulting in the 
production of a pre-mRNA molecule comprised of exons alone. 
 The final step in nuclear processing of mRNA is the addition of a 3' 
polyadenylated tail consisting of approximately 200 adenine residues. Prior to the 
addition of poly(A) tail, the pre-mRNA must be cleaved at a site present between a highly 
conserved AAUAAA sequence and a uracil or GU-rich motif known as a downstream 
sequence element (DSE) [27]. This cleavage is performed by two multisubunit protein 
complexes in association with two essential factors, cleavage factors I and II, which 
direct cleavage of the pre-mRNA. Poly(A) polymerase, the enzyme catalyzing the 
addition of the poly(A) tail, is usually required within the cleavage reaction complex and 
directs the poly(A) addition. Poly(A) binding protein II then binds to the emerging 
poly(A) tail and also enhances the processivity of the poly(A) polymerase [27]. Once all 
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three processes are complete, the now mature mRNA can be exported from the nucleus to 
the cytoplasm where it is capable of either undergoing active translation or becoming 
translationally repressed. 
1.6 Emerging paradigm of Gene regulation, cytoplasmic regulation of mRNA  
 Once messenger RNA (mRNA) is exported from the nucleus into cytosolic 
compartments, the regulation of gene expression is further maintained through the 
processes of (i) translation, (ii) mRNA degradation (decay) and (iii) mRNA storage. The 
fate of transcripts, whether they are actively translated, degraded or stored is controlled 
and reflected by the composition of messenger ribonucleoprotein (mRNP) complexes 
which interact with mRNAs [28]. The flux of mRNP remodeling directs cytoplasmic 
mRNAs among complexes such as (i) the polysome, for the translation process, (ii) 
processing bodies (PBs) and (iii) stress granules (SGs) for degradation and storage, 
respectively [29]. The composition of mRNPs play a vital role in dictating the fate of 
transcripts with major mRNP remodeling occurring throughout the mRNA cycle. 
mRNAs may be actively shuttled between each of the three mRNPs, resulting in dynamic 
alterations in mRNP composition. An illustration of this dynamic cycle is shown below 
(Figure 1.1).  
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Figure 1.1 Cytoplasmic regulation of mRNA fate 
 Cytoplasmic mRNAs are engaged in three possible cellular processes (i) active 
translation, where polysome structures are formed, (ii) degradation via processing bodies 
and (iii) storage in stress granules. The image was modified from [30]. 
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(i) Regulation of translation 
 During translation, the 40S and 60S ribosomal subunits are recruited onto mRNA 
transcripts by a number of eukaryotic translation initiation factors (eIFs) [31]. The 
recruitment of factors, referred to as the initiation phase, can be directed in either a 7-
methylguanylate (m
7
G) 5'-cap dependent or independent manner. During cap-dependent 
initiation the m
7
G 5'-cap structure is recognized by the initiation factors eIF4F, eIF4E and 
eIF3 which then recruit the 40S ribosomal subunit [31]. The dependency on the m
7
G 5'-
cap structure allows for fine-tuning of gene expression by enhancing or repressing the 
assembly and activity of the cap-binding complex through the reversible phosphorylation 
of translation factors. Conversely, during cap independent translation an RNA structure, 
referred to as an internal ribosome entry segment (IRES), aids in the assembly of 
translational machinery at a position close to the initiation codon [31]. In either form of 
initiation, once the ribosomal subunits are recruited, a downstream scanning for the 
translation initiation codon (AUG) occurs and translation of a nascent polypeptide is 
performed. These repetitive rounds of translation initiation, elongation and termination 
occur in the mRNPs referred to as polysomes [32]. 
(ii) Regulation of mRNA decay 
  Cytoplasmic mRNA turnover is a vital aspect of cellular physiology and is a key 
factor in gene expression. In eukaryotes, the degradation of mRNA occurs by three 
cellular mechanisms: (i) endonucleolytic cleavage, (ii) specialized quality control 
pathways or (iii) deadenylation dependent 3' to 5' decay [33].  
 Endonucleolytic cleavage is the degradation of mRNA transcripts without the 
prior need for transcript deadenylation. In yeast, mRNAs stalled in translation elongation 
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were shown to be recognized and targeted for endonucleolytic cleavage involving 
proteins similar to translation termination factors such as the eukaryotic release factor 
3(eRF3) [34]. This type of mRNA cleavage is also responsible for RNA-mediated gene 
silencing (RNAi), resulting in the formation of 21-23 nucleotide RNA species that are 
used in the targeting of the RNAi-induced silencing complex [33]. To monitor mRNA 
biogenesis, quality control mechanisms occur in eukaryotic cells which cause the rapid 
degradation of aberrant mRNAs [33]. These aberrant mRNAs are identified as those 
transcripts with defective structures within the 5'-cap, start/stop codons or poly(A) tail. 
For transcripts exhibiting a premature stop codon, non-sense mediated decay (NMD) 
occurs which is the process of mRNA degradation without the prior necessity of poly(A) 
tail shortening [33]. This process is responsible for the reduction of truncated proteins. 
Similarly, the decay of transcripts with an absence of a stop codon is performed via 
nonstop decay, which directs target mRNA to the exosome [33]. 
 Deadenylation dependent degradation of mRNA occurs via two pathways, both of 
which begin by the shortening of the poly(A) tail by the action of deadenylases [33]. In 
yeast, the first pathway results in the degradation of mRNA in a 3' to 5' direction 
catalyzed by the exosome. The exosome is a large complex of exonucleases which 
function in RNA degradative and processing events [33]. In the second pathway, 
following the shortening of the poly(A) tail, the decapping of the m
7
G 5'-cap structure is 
performed by a holoenzyme consisting of Dcp1p and Dcp2p enzymes. The decapped 
transcripts are then digested by a 5' to 3' exonuclease [33]. Mutagenesis resulting in the 
loss of either of the subunits, Dcp1p or Dcp2p, results in a complete loss of decapping in 
vivo, identifying the necessity of the holoenzyme in this pathway [34]. Furthermore, 
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Dcp2p was identified as the catalytic subunit required for decapping while Dcp1p acts to 
stimulate the activity of Dcp2p by increasing substrate interaction [34]. The activity of 
Dcp1p/Dcp2p results in the release of m
7
GDP, leaving a product consisting of a 5'-
monophosphate bound to mRNA [35]. This product is the preferred substrate for 
exonucleases, resulting in degradation of transcript. The expression of decapping 
enzymes and presence of aggregated decapping factors within sub-cellular structures in 
many organisms suggests that this mechanism is conserved throughout eukaryotes.  
 Decapping of mRNA is controlled by three major factors; the length of the 
poly(A) tail, the translation status of the transcript and the ability of mRNA to assemble a 
decapping complex [34]. The commonality of all these factors is the influence of mRNA-
specific binding proteins which regulate decapping by either stimulating or inhibiting the 
action of enzymes. The action of PABP, specifically its ability to protect the poly(A) tail 
from degradation, inhibits decapping and subsequent mRNA degradation. PABP is 
believed to act in decapping inhibition by two discrete mechanisms. Firstly, its physical 
interaction with eIF4G, a component of the cytoplasmic cap-binding complex, may 
inhibit decapping by enhancing mRNA translation. Interestingly, this stabilization of the 
cytoplasmic cap-binding complex alone has been shown to inhibit decapping as well 
[36]. The second mechanism of inhibition stems from in vitro studies which suggested 
that PABP can bind directly to the cap structure and actively inhibit decapping [37]. The 
second factor influencing decapping of mRNAs is the assembly of various protein 
complexes which act to enhance the interaction of the decapping enzyme [34]. For 
example, complexes in yeast containing Lsm1-Lsm7 proteins, Pat1p and Dhh1p have 
been shown to enhance the decapping action of the Dcp1p/Dcp2p holoenzyme by aiding 
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in the proteins recruitment to target mRNA [38]. For decapping to occur, there must be a 
transition of the mRNA from a translationally active complex to an mRNP complex that 
lacks translation factors. The dissociation of the cap-binding complex marks the 
transition from active translation to transcript decay. This is followed by the formation of 
specific cytoplasmic foci, referred to as processing bodies (PBs), where decapping factors 
and 5' to 3' exonucleases are recruited [34].  
(iii) Regulation via RNA storage in sub-cellular structures 
 Processing bodies: PBs are constitutive cytoplasmic aggregates containing 
translationally repressed mRNPs. These RNA granules consist of non-translating mRNAs 
and interacting proteins involved in translational repression, mRNA decay and RNA 
interference [30]. Transcripts appear to be transiently associated with PBs, and if not 
degraded, are released from PBs and incorporated back into active translation [28]. 
Transcripts could be targeted for 5' to 3' decay or remain translationally inactive, is 
dependent on variations in the composition of these PBs [28]. In humans for example, the 
interaction of Puf family members with the 3' untranslated regions (UTRs) of transcripts 
and the Pop2p subunit of the Ccr4/Pop2/Not complex (found within PBs), directs 
transcripts for repression and decay [29]. Similarly, the association of Dhh1 with mRNAs 
in yeast results in the shuttling of transcripts to PBs [39]. Although the complete 
composition of PBs has yet to be identified, PBs have core protein components consisting 
of (i) the decapping enzyme Dcp1p/Dcp2p, (ii) activators of decapping and (iii) a 5' to 3' 
exonuclease [29]. These core proteins can be referred to as the 5' repression-decay 
complex.  
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 Prior to PB formation, transcripts are released from the polysomes. The 
subsequent remodeling of mRNP complexes produces an mRNP containing the 5' 
repression-decay complex [28]. In accordance with this, ribosomal subunits have not 
been identified in PBs. The treatment of cells with translation elongation inhibitors, such 
as lactimidomycin, prevents PB assembly and traps mRNP complexes within the 
polysome [40, 41]. In comparison, inclusion of 5' repression-decay complexes have been 
shown to be necessary for PB formation. The recruitment of this complex can occur 
either by an intrinsic mRNA affinity or through the action of mRNP specific factors [28]. 
Specific structural or sequence targets within the mRNA transcript may result in the 
recruitment of decapping factors and subsequent targeting to PBs. Alternatively, 5' 
repression-decay factors interact with mRNA-specific complexes involved in translation 
initiation inhibition or mRNA decay, resulting in PB assembly [33]. The importance of 
the 5' repression-decay complex has been exhibited by studies which show an enrichment 
of 5' decay factors within PBs as well as an increase in PB formation occurring from over 
expression of individual factors [28]. Also, depletion of factors which recruit the 5' 
repression-decay complex cause an impairment in PB assembly [28]. In addition to PBs, 
SGs have also been shown to play a vital role in mRNA regulation during cellular stress. 
 Stress granules: In contrast to PBs, SGs are transient cytoplasmic aggregates 
which occur in response to the cellular exposure to an environmental stress. Stresses, 
such as heat shock, result in a sudden arrest of translation which leads to polysome 
disassembly [42]. The disassembly and subsequent rearrangement of mRNPs could 
initiate the formation of SGs, which act as emergency storage locations for mRNAs. The 
exposure of cells to translation initiation impairment drugs, such as hippuristanol, and the 
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depletion of initiation factors can induce the formation of SGs [28, 42]. The core 
components of SGs, which act as markers for all SGs, include components of the small 
ribosomal subunit, translation initiation factors eIF3 and eIF4 and PABP [42]. The 
composition of the protein complex confirms that these granules are aggregates of 
mRNPs stalled in the translation initiation step [28]. Several other classes of proteins 
have been identified in SGs, including mRNA-binding proteins linked to translational 
silencing (i.e T-cell internal antigen-1; TIA-1) and RNA decay (i.e argonaute proteins; 
AGO). However, these proteins are not present in all SGs [42]. According to Anderson 
and Kedersha (2007), the assembly of SGs has been divided into three distinct stages 
[42]. First, the stalling of translation initiation and the formation of the 48S mRNP is 
caused by either drug-induced inactivation of eIFs or stress-induced eIF2α 
phosphorylation. The formation of SGs is then enhanced by the interaction of SG-
nucleators with the 48S mRNP during a process termed primary aggregation [42]. The 
transcripts then bind to other proteins which undergo protein-protein interactions amongst 
themselves during secondary aggregation, thereby allowing for the subcellular SG 
structures to become microscopically visible [42]. The fate of these repressed mRNAs is 
determined by their association with specific RNA-binding proteins present within the 
SGs. These transcripts could (i) remain stored, (ii) be reinitiated into translation or (iii) 
selected for decay. Although the direct observation of mRNA shuttling between PBs and 
SGs has yet to occur, several proteins such as Dhh1 are shown to be capable of shuttling 
in and out of these granules [30]. Furthermore, PBs and SGs have been seen to contain 
the same mRNA species [30]. Intriguingly, throughout this dynamic remodeling process, 
RNA helicases continually emerge in several stages of translational repression. These 
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proteins have also been shown to colocalize within both SGs and PBs and affect the 
stability of these granules [30]. These helicases may alter the composition of mRNPs or 
promote mRNP formation by their activity to remodel RNA-protein complexes, thereby 
dictating the fate of transcripts [30]. The subsequent alterations result in granule stability 
and finally the recruitment of specific factors to mRNPs [30]. These functions suggest the 
important role of these RNA helicases in mRNA storage, repression and subsequently, 
gene regulation. 
1.7 Helicases 
 Helicases are nucleic-dependent NTPases capable of unwinding DNA or RNA 
duplex substrates [43]. Their functions are defined by their ability to translocate 
directionally along the nucleic acid phosphodiester backbone and to simultaneously 
unwind double-stranded regions by utilizing energy gained from ATP hydrolysis [44]. 
Helicases play vital roles in various cellular processes, including replication, translation, 
ribosome synthesis, RNA metabolism and nuclear export processes [45]. All helicases 
contain central core domains identified by signature motifs which couple NTP binding, 
NTP hydrolysis and the conformational changes in protein structure, resulting in DNA or 
RNA remodeling [44]. These signature motifs include: (i) the conserved motifs, Walker 
A and B, involved in the binding and hydrolysis of the NTP and (ii) an “arginine finger” 
that plays a key role in energy coupling to unwinding activity [44].  
 Using their consensus sequences and signature motifs, helicases, which are 
generally composed of multiple repeating units, are classified into different superfamilies, 
families, and subclasses (Fig. 1.2). The first tier of classification is based on the features 
of their central cores whether they contain (i) two RecA-like domains, (ii) six RecA-like 
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domains arranged in a (hexameric) toroid or (iii) six AAA
+
 domains arranged in a 
(hexameric) toroid [44]. To further categorize helicase members into different 
subfamilies, two additional criteria were used. First, their enzymatic activities are towards 
single and/or double stranded nucleic acids as their substrates [44]. The helicase members 
that utilize single-stranded nucleic acids as their substrates are identified as α helicases, 
whereas those using double stranded nucleic acids as their substrates are β helicases [44]. 
For example, the members of Superfamily 1 (SF1) are α helicases because they will 
engage only single stranded nucleic acids, while the members of SF6 are β helicases [44]. 
Second criterion used for grouping helicase members is their translocation polarity. When 
the helicase members translocate from 3’- to 5’-terminus, they are called type A 
helicases. Those, that translocate from 5’- to 3’-terminus, are type B helicases [44]. With 
these classification criteria, six helicase superfamilies are formed (Fig. 1.2).  
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Figure 1.2 Classification of Helicase Superfamilies 
 
 Helicases can be classified into six major superfamilies: SF1 and SF2 are 
composed of two repeating subunits of RecA-like domains while SF3-SF6 helicases are 
composed of 6 repeating subunits of either RecA-like or AAA
+
 monomers. 
Classifications are also based on translocation polarity (3'-5' as Type A or 5'-3' as Type 
B) and whether the nucleic acid substrate is single (α) or double stranded (β). 
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The core domain structure is used in the identification of each helicase 
superfamily. Specifically, SF1 and SF2 helicases contain a core consisting of a tandem 
repeat of two RecA-like domains while SF3-6 helicases contain a core consisting of six 
individual RecA- or AAA
+
-like domains arranged in a toroid. The common features of 
these core structures will be further discussed and are illustrated below (Fig 1.3). 
 
 
Figure 1.3 Representative core structures of helicase superfamilies. 
 (Left) SF1 and SF2 helicases contain a tandem repeat of RecA-like domains (N- 
and C- core). An NTP analogue (black) is shown at the interface of the core domains. The 
Walker A (1) and B (2) motifs are located on the N-core side of the cleft. Motif 6 
contains the conserved arginine finger residue required for ATP coupling. (Right) SF3-6 
helicases contain a core of six individual RecA- or AAA
+
-like domains in a toroid. This 
configuration results in six nucleotide-binding pockets; shown to be occupied with NTP 
analogues (black). H1 and H2 are equivalent to the Walker A and B motifs which are 
located on the opposite side of the cleft compared to the conserved arginine finger. This 
image was modified from [44].  
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1.8 Main characteristics of helicase superfamilies (SFs) based on their core domains 
Hexameric RecA-like domain: SF4 and SF5 helicases contain six units of RecA-
like domains, which are homologous to the bacterial recombinase-A (RecA) protein, 
arranged to form a barrel-like structure (Fig. 1.2, right panel) [44]. RecA was first 
identified in E. coli to function in the repair and maintenance of nicked DNA [46]. 
Among SF3 and SF4 helicase members, each RecA-like monomer contains three 
domains: (i) an amino domain which functions in RecA polymer formation, (ii) a central 
domain involved in nucleotide and NTP binding, and (iii) the carboxy domain which 
facilitates interfilament association [46]. The central domain contains two nucleotide 
binding regions, one for single and another for double stranded nucleotides, as well as 
one ATP binding region known as the phosphate binding loop (P-loop) [46]. The RecA-
like hexameric structure is responsible for the forming of six nucleotide binding pockets, 
one per domain interface. It is noted that all members of SF4 and SF5 superfamily have 
the conserved hexameric core and type B translocation directionality [44]. Interestingly, 
there is no functional commonality among members. For example, SF4 helicases, which 
were first identified in bacteria and bacteriophages, share five conserved motifs (H1, 
H1a, H2, H3 and H4) and act as replicative helicases [47]. SF5 helicases, whose best 
example is Rho helicase, are functionally responsible for termination of transcription in 
bacteria [23]. 
ATPases Associated with diverse cellular Activities (AAA
+
): The core domain of 
SF3 and SF6 helicase members contain six subunits of AAA
+
 core domain organized in a 
toroid (Fig. 1.3, right panel) [44]. Notably, the proteins that contain AAA
+
 domain are 
also considered as members of P-loop NTPases [48]. In addition, the proteins containing 
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AAA
+
 domain have the Walker A and B motifs which are responsible for nucleotide 
binding and nucleotide hydrolysis [49]. These AAA
+
 domain containing proteins 
characteristically carries a conversed catalytic glutamate which is not seen in other 
NTPases [50]. The AAA
+
 domain is highly conserved and contains approximately 200-
250 amino acid residues [48]. Three critical motifs were described within the AAA+ 
conserved domain and are known as (i) sensor 1, (ii) sensor 2 and (iii) 'box' sequences 
[51]. Sensor 1 contains a conserved polar residue, which is aspargine, threonine or 
histidine, to function as a nucleotide sensor for binding and hydrolysis by interacting 
directly with the γ-phosphate of ATP [50]. Sensor 2 contains a conserved arginine residue 
and functions in the binding and hydrolysis of ATP as well as the communication and 
movement between subunits [50, 51]. Finally, the "box" motifs are believed to function in 
ATP hydrolysis as well as intersubunit communication. SF3 and SF6 members vary in 
functions and non-central core structures [51]. SF3 helicases were originally identified in 
DNA and RNA viruses, such as parvo- and papillomaviruses, and are associated with 
activities such as origin recognition and unwinding [47]. These SF3 helicase members 
share four conserved motifs (A, B, B' and C) and exhibit type A translocational 
directionality [44]. On the other hand, the numbers of SF6 helicase members are limited. 
To date, SF3 has only the archeal and eukaryotic mini chromosome maintenance (MCM) 
protein complex and the RuvB proteins as the members of the superfamily [44, 52]. 
MCM is considered as the main eukaryotic replicative helicase and exhibits both A and B 
type directionality while RuvB proteins work as a dsDNA translocases which processes 
Holliday junctions [44].  
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RecA-like domain: SF1 and SF2 helicases contain two identical units of RecA-
like domains which are connected by a flexible linker, forming a cleft which contains the 
ATP-binding site (Fig. 1.2, left panel) [53]. The N- core domain contains the conserved 
motifs I-III and the Q motif, while the C- core domain is composed of motifs IV-VI [54]. 
These motifs will be discussed in further detail in Section 1.10. Target nucleic acids 
become associated opposite the ATP-binding site and forms interactions which spans 
across both domains (Fig. 1.2, left panel) [44]. As shown by X-ray crystallography and 
various biochemical studies, the binding and hydrolysis of ATP is facilitated by the 
closure of the cleft between the two RecA-like domains, resulting in nucleic acid 
unwinding [55].  
 The structural features of SF1 and SF2 helicase members have continuingly been 
subjected to extensive analyses. For example, with intense structural analyses, the 
formerly known seven conserved motifs of SF1 were resolved to contain more unique 
motifs within, which gave rise to two SF1 subfamilies, names SF1A and SF1B. Notable, 
SF1 members utilize single-stranded nucleic acids as their substrate, while SF2 members 
could accept single or double stranded nucleic acids are their substrates. SF1 and SF2 
exhibit A and B type directionality [44].  
1.9 SF2 helicases  
SF2 contains the largest number of characterized members which are complex by 
nature. The major subfamilies are: (i) DEAD-box RNA helicases, (ii) the RecQ-like 
family and (iii) the Snf2-like enzymes [44]. Uniquely, the members of SF2 subfamilies 
are capable of using either RNA or DNA as their substrates [53]. More specifically, 
DEAD-box helicases interact with RNA, while RecQ-like and Snf2-like helicases use 
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DNA as their substrates. Aside from sharing core structural feature, SF2 helicases contain 
auxiliary domains on their C- and N- termini to confer specificity or complementary 
catalytic activities [56]. More specifically DEAD-box RNA helicase subfamily play vital 
role in cellular activities including the disruption of mRNPs and the remodeling of RNA.  
1.10 DEAD-box RNA Helicases 
 DEAD-box RNA helicases were first described by Gorbalenya et al.(1989), when 
a group of NTPases were defined based on sequence similarity to the eukaryotic initiation 
factor 4a (eIF4a) to contain several common sequence elements (Fig.1.4) [57]. Since 
then, DEAD-box RNA helicases have been classified as the largest helicase family of 
SF2. The mode of RNA binding in DEAD-box RNA helicases is highly conserved 
throughout the family [58]. The two central core domains make a contact to its RNA 
substrate in a non-sequence-specific manner spanning over any consecutive five 
nucleotides [45]. The interaction involves exclusively the sugar backbone of the RNA. 
Bound to the enzyme, RNA is bent in a conformation which differs from those seen in 
most SF2 helicases [45]. In this single stranded RNA (ssRNA) conformation, the RNA 
undergoes a sharp bend due to ionic and hydrogen bond interactions with several motifs 
within domain 1 (Fig. 1.4) [59, 60]. The resulting ssRNA structure inhibits the formation 
of a double stranded helix, giving rise to RNA unwinding [60]. This local strand 
separation is unique to DEAD-box RNA helicases, as it abolishes the need for 
translocation in order for strand separation to occur [45]. 
 Additionally, most DEAD-box helicases contain auxiliary domains known as N-
terminal and C-terminal extensions (NTE/CTE, Fig 1.4). These extensions vary in length 
and composition from one protein to another and have been shown to interact with RNA 
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or other proteins [55]. These interactions characterize specific DEAD-box RNA 
helicases, thereby targeting them for specific physiological functions [58]. Furthermore, 
these auxiliary domains have been shown to result in protein dimerization, regulate 
functional properties of the RecA-like core domains as well as contribute additional 
enzymatic activities [45].  
 
Figure 1.4 Conserved motifs of the DEAD-box RNA helicase subfamily 
 DEAD-box RNA helicases are composed of 13 conserved motifs: motifs I-VI and 
the Q motif. Motifs interacting with RNA are boxed in white while those involved with 
ATP are in dark grey. Motif III which is involved in coupling ATP binding/hydrolysis 
with helicase activity is in light grey. The Q motif is known to be specific to the family of 
DEAD-box helicases while Motif II contains the conserved D-E-A-D amino acid 
sequence. NTE and CTE are the auxiliary N- and C- terminal domains, respectively. The 
domains were resolved from the yeast DEAD-box protein Mss116. This image was 
modified from [45, 61].  
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1.11 Structural features of DEAD-box RNA helicases 
 DEAD-box RNA helicases participate in diverse cellular functions in a wide 
variety of organisms, ranging from S. cerevisiae to Homo sapiens. Their functions have 
been implicated in almost all aspects of RNA metabolism including transcriptional 
control, nuclear mRNA export, translational regulation and RNA decay [58]. To be 
classified as a DEAD-box RNA helicase, the protein must harbor 13 conserved motifs 
(Fig. 1.3). Herein the nature and function of each conserved motif, namely the Q motif, 
motifs I, Ia, Ib, Ic, II, III, IV, IVa, V, Va, Vb and VI will be addressed [45].  
The Q motif which was identified upstream of motif I and is comprised of a conserved 
nine amino acid sequence [62]. The sequence of this motif is as follows: GaccPohlQ; 
where "a" is an aromatic group, "c " is a charged group, "o" is an alcohol, "h" is a 
hydrophobic group and "l" is an aliphatic group [45]. This motif is characterized 
specifically by a conserved glutamine residue which is present in 99% of protein 
sequences analyzed [62]. Although the invariant glutamine residue is present in many 
helicases, several other conserved residues within the Q motif are only conserved among 
DEAD-box proteins. As a result, the Q motif is suggested to be specific to DEAD-box 
helicases [61]. This motif is necessary for efficient binding of ssRNA and conformational 
changes occurring due to nucleotide binding and ATP hydrolysis. Therefore it has been 
suggested that the Q motif acts as a sensor of the bound nucleotide and regulator of 
subsequent ATPase activity [45]. Furthermore, the base pair of the adenine nucleotide 
interacts specifically with the conserved glutamine residue, resulting in a strong 
preference for ATP over other nucleotide triphosphates [45]. 
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Motif I (AxTGxGKT) is known as the Walker A motif is vital for both ATPase and 
helicases activity. It was found to function in NTP binding by coordination of a Mg
2+ 
ion 
as well as by forming hydrogen bonds with pyrophosphates of target nucleotides [63]. 
Mutational studies targeting the alanine, lysine or final threonine residues abolished 
ATPase activity and reduced the affinity for and rate of ATP hydrolysis [56]. 
Furthermore, this motif is crucial in regulating protein activity through interactions with 
the phosphate of nucleotides, motif II, motif III and the Q motif [56]. 
Motif II (DEAD) is known as the Walker B motif and is necessary for ATPase activity 
[63]. Along with the Walker A motif, these motifs are not only present in DEAD-box 
helicases, but are common to all helicases as well as numerous NTPases. Mutational 
studies reveal similar results as those seen with the Walker A motif, with abolished 
ATPase and helicase activity without altered RNA binding [56]. Furthermore, the 
presence of the amino acid sequence Asp-Glu-Ala-Asp in this motif inspired the name of 
this family of helicases. 
Motif III (SAT) has been suggested to play a role in coupling ATP binding and 
hydrolysis with helicase activity [56]. This concept originated due to experimental 
mutations resulting in interrupted substrate unwinding without affecting ATP binding and 
hydrolysis. However, the role of this motif remains ambiguous due to mutations in motif 
III varying the impairment of protein function between members present in the SF1 and 
SF2 superfamilies [56].  
Motif VI (HRIGRTGR) was determined to function in both ATPase and RNA binding 
activity and is located at the interface of domains 1 and 2. Mutational analysis resulted in 
the abolishment of helicase activity through the impairment of ATP binding and 
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hydrolysis [56]. These studies targeted the conserved histidine, the second arginine as 
well as the glutamine residues. Furthermore, it was determined that the second arginine 
indeed interacted with the gamma-phosphate of the ATP, confirming the motif function 
in the coupling of NTP hydrolysis with helicase activity [56].  
Motif Ia (PTRELA) and Ib (TPGR) are present in domain 1 and do not participate 
directly in ATP binding or hydrolysis however, are necessary for RNA binding in 
association with motifs IV and V [56]. Although motifs I, II and II have been well 
characterized, the roles of motifs Ia, Ib, IV and V remain ambiguous, as the motifs have 
been less studied [45]. Studies by Schwer and Meszaros (2000) have shown that motif Ia 
may also participate in structural rearrangements facilitated by ATP binding and 
hydrolysis [64]. Motif IV is poorly studied, resulting an unclear consensus sequence for 
the motif. This motif is found at the bottom of domain 2 and has been suggested to play a 
role in the binding of ssRNA [56]. Finally, Motif V (TDxxARGID) is suggested to 
function in RNA-binding in conjunction with motifs Ia, Ib and IV. Studies of this motif 
have also implicated its role in signal transmission of RNA binding to the ATPase 
domain and subsequent regulation and hydrolysis of ATP. It was also determined that 
contacts do occur between motif Va and the ribose sugar, however the role of these 
contacts is unknown [56]. 
1.12 Important homologues of DEAD-box RNA helicases 
 With intense studies, there are hundreds of members documented. Herein three 
members of DEAD-box RNA helicases, whose structural and functional features are 
highly related to the newly characterized DEAD-box RNA helicase member described in 
this study, will be reviewed.   
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Yeast DEAD/H helicase-1 (Dhh1) is one of over twenty DEAD-box proteins identified 
in Saccharomyces cerevisiae. Dhh1 plays a vital role in mRNP remodeling during mRNA 
metabolism and decay [39]. Mutagenesis analysis has shown that Dhh1 knock-out 
mutants have (i) prolonged half-life of target mRNAs, (ii) accumulated deadenylated 
transcripts and (iii) the lack of removal of the 5' m
7
G cap [39]. Furthermore, it has been 
that Dhh1 has the physical association with Pop2p (deadenylase) and Dcp1a in 
processing bodies [65]. Taken together, these studies strongly suggested the involvement 
of Dhh1 in mRNA turnover and its specific role in mRNA decay.  
 It has also been shown that Dhh1 is not only involved in mRNA decay, but also 
plays a role in the storage of mRNAs during environmental stress [66]. Under glucose 
deprivation, cellular localization of Dhh1 was within stress granules, therefore indicating 
a possible role in translational repression which does not involve mRNA degradation 
[66]. Furthermore, yeast cells whose Dhh1 expression was abolished showed deficient in 
stress granules formation [66]. Intriguingly, the presence of Dhh1 in both stress granules 
as well as processing bodies indicates a possible role in the shuttling of mRNAs between 
the two cellular compartments.  
Conserved germline helicase-1 (CGH-1) is a DEAD-box helicase found in 
Caenorhabditis elegans and has been found to function in translational repression as well 
mRNA degradation [67]. Biochemical analyses have shown that CGH-1 functions by 
associating with maternal mRNAs to protect them from degradation. These studies have 
shown that CGH-1 does not only play a vital role in translational repression of maternal 
mRNAs by means of storage in germline specific granules (P-granules) during oocyte 
development but also protects target mRNAs by enhancing mRNA stability [67]. 
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Although the function of CGH-1 has been identified, the mode by which that function is 
performed remains elusive. A model describing the involvement of CGH-1 in maternal 
mRNA storage and repression has been hypothesized by Parker and Rajyaguru (2008) 
and may have implications pertaining to this studies.  
 In this model, CGH-1 is involved in translational repression by forming mRNPs 
which accumulate in P-bodies. These cellular foci may result in the degradation of target 
mRNAs by the recruitment of decapping enzymes [67]. This concept is centralized 
around the ability of CGH-1 homologues, such as Dhh1, to interact with decapping 
enzymes and other components of P-bodies [66]. Furthermore, CGH-1 would transition 
mRNAs from P-bodies to stress granules where they may interact with proteins involved 
in translational activation. The evidence for this is the fact that CGH-1 has been purified 
in RNA-protein complexes including poly(A) binding protein and other proteins which 
are known components of stress granules [67]. 
Development of zygote inhibited (DOZI) is a DEAD-box member found in Plasmodium 
berghei and shown to function in translational repression in the female gametocyte [68]. 
Two specific mRNAs, p25 and p28, which encode proteins necessary for zygote 
development, were found to be translationally repressed within cytoplasmic foci until 
after gamete formation and fertilization [68]. Intriguingly, immunofluorescence studies 
identified the colocalization of DOZI within the same mRNP structures. 
Immunoprecipitation studies and subsequent analyses identified the interaction of 
substantial amounts of both transcripts, as well as many other transcripts, with transgenic 
DOZI protein [68].  
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 Mutagenesis showed that DOZI null mutants exhibited a total loss of development 
of zygotes into mature ookinetes while maintaining normal production of gametocytes 
and gametes [68]. Furthermore, Northern analysis and oligonucleotide microarray studies 
showed the loss of p25 and p28 transcripts as well as the reduction of another 370 
transcripts; many of which were involved in ookinete motility and invasion and 
previously shown to be translationally repressed [68]. Interestingly, 92 transcripts were 
shown to increase in abundance which may indicate further functions of DOZI in mRNA 
regulation [68]. Overall, the study identified DOZI as a central player in the repression 
and regulation of gametocytespecific transcripts. Furthermore, the loss of protein 
expression severely hindered the ability of the parasite to regulate mRNAs in the female 
gametocyte. 
 When the composition of the cytoplasmic foci was further analyzed, sixteen major 
protein factors were present within these structures, including: (i) PABP, (ii) CAR-
I/Trailer Hitch Homolog (CITH), (iii) eIF4E, (iv) enolase and (v) Acetylation Lowers 
Binding Affinity proteins 1 and 2 (Alba 1 and Alba 2) [69]. These studies suggest that 
DOZI could act primarily in mRNA storage rather than degradation and is a translational 
repressor necessary for proper zygote development [69]. Furthermore, the study also 
suggests that such mRNPs are evolutionarily conserved in protozoans. The regulation of 
gene expression could be controlled by the formation of mRNPs to ensure the stability 
and storage of mRNAs.  
1.13 DEAD-box RNA helicases in Toxoplasma gondii  
 During the complex life cycle of T. gondii there is a necessity for mechanisms to 
be in place which regulate gene expression during the parasitic exposure to various 
33 
 
environmental stresses throughout the continuous rounds of host invasion and egress. The 
discovery of DEAD-box RNA helicases as vital components in post-transcriptional 
regulatory pathways in several organisms has thereby lead to the current study of 
homologous RNA helicases in Toxoplasma gondii. Bioinformatic analyses have 
identified 81 putative proteins with functional implications in gene regulation; 20 of 
which contain conserved amino acid sequence motifs relating to the DEAD-box RNA 
helicase family. Another 26 proteins were identified as putative ATP-dependent RNA 
helicases due to the presence of both ATP and nucleotide binding regions. A summary of 
the DEAD-box and ATP-dependent RNA helicase genes can be found in Appendix A.  
 A member of the DEAD-Box RNA helicase family in Toxoplasma exhibits a high 
sequence homology to several highly characterized DEAD-box RNA helicases. These 
homologues, which were previously discussed above, play vital roles in the post-
transcriptional gene regulation of target transcripts in their respective organisms. The 
amino acid sequence alignment of the proteins is shown in Figure 1.5. The RNA helicase 
exhibited a sequence similarity of 68% to Dhh1, 67% to CGH-1 and 81% to DOZI. Due 
to the high sequence homology to DOZI, this RNA helicase will be referred to as 
TgHoDI (Toxoplasma gondii Homologue of DOZI; gene ID Tggt1_089230).  
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DHH1       -------------------------------------------------------------MGSI 
CGH-1      ----------------------------------------------------------------- 
DOZI       ------------------------------------------------MSYKTNCVASNANTNAL 
TgHODI     MSAAYYTRRPGLSGSPYPQSQNGSGERNANQGQGPAPYGYPPQQRMQHFSQPQNSVPSQPANPA- 
                                                                       
 
DHH1       N-NNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMGIFEAGFEK 
CGH-1      MSGAEQQQIVPANNGDENWKAGLNLPAKDRRFKTADVTDTKGVEFEDFCLGRDLLMGIFEAGFEK 
DOZI       NNSNNLNKIEDNVIFDEAWKKKILEPLKDPRYKTEDVTKTKGNEFEDYFLKRELLMGIFEAGFEK 
TgHODI     -----HVDPNNNPEGDEGWKSKVVLPPKDNRVKTEDVTKTKGTDFEEYFLRRELLMGIFEAGFEK 
                  .       *. **  :  * ** * :* ** .***  **:: * *:******* *:** 
 
DHH1       PSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIMVPTRELALQTSQV 
CGH-1      PSPIQEASIGVALTGQDILARAKNGTGKTGAYCIPVIEKIQPALKAIQAMVIVPTRELALQTSQI 
DOZI       PSPIQEESIPVALAGKNILARAKNGTGKTAAFAIPLLEKCNTHKNFIQGLILVPTRELALQTSAM 
TgHODI     PSPIQEASIPIALAGKNILARAKNGTGKTAAFSIPLLEKCQTSKRYIQGLILVPTRELALQTSAV 
           ****** :* :*::*::************.*: ** :** :   . **.:::*********** : 
 
DHH1       VRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLASRKVADLSDCSLFIMDEAD 
CGH-1      CVELSKHIQLKVMVTTGGTDLRDDIMRLNGTVHLVIATPGRILDLMEKGVAKMEHCKTLVLDEAD 
DOZI       IKELGKHMKIQCMVTTGGTSLREDIMRLYNAVHILCGTPGRILDLANKDVANLSGCHIMVMDEAD 
TgHODI     VKAIGKHMNVQCMVSTGGTSLRDDIMRLYNPVHVLCGTPGRILDLANKGVADLSNCHMVVMDEAD 
              :.**  :. **:****.**:**:**   **:: .****:*** .: **.:. *  .::****  
 
DHH1       KMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKHLHKPYEINLMEELTLKGITQYYA 
CGH-1      KLLSQDFQGILDRLINFLPKERQVMLYSATFPNTVTSFMQKHMHKPYEINLMEELTLLGVTQYYA 
DOZI       KLLSPEFQPIVEELMKFLPKEKQILMYSATFPVTVKEFRQIYLSDAHEINLMDELTLKGITQYYA 
TgHODI     KLLSAEFQPIVEELIKFVPRERQILMYSATFPVTVKDFKHKYLPDAHEINLMDELTLKGVTQYYA 
           *:** :*: *::.::.*:*  :* :::***** **..*   :: . :*****:**** *:***** 
 
DHH1       FVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLAKKITDLGYSCYYSHARMKQQERNKVFHE 
CGH-1      FVQEKQKVHCLNTLFRKLQINQSIIFCNSTQRVELLAKKITEIGYSCYYIHSKMAQNHRNRVFHD 
DOZI       FVKERQKVHCLNTLFAKLQINQAIIFCNSITRVELLAKKITELGYSSFYIHARMSQTHRNRVFHD 
TgHODI     FVEERQKVHCLNTLFSKLQINQAIIFCNSVTRVELLAKKITELGYSCFYIHARMMQSHRNRVFHD 
            **:*:**:******* ******:****** **********::***.:* *::* * .**:***: 
 
DHH1       FRQGKVRTLVCSDLLTRGIDIQAVNVVINFDFPKTAETYLHRIGRSGRFGHLGLAINLINWNDRF 
CGH-1      FRQGNCRNLVCSDLLTRGIDIQAVNVVINFDFPRNAETYLHRIGRSGRFGHLGVAINLITYEDRH 
DOZI       FRNGACRCLVSSDLFTRGIDIQSVNVVINFDFPKNSETYLHRIGRSGRYGHLGLAINLITYEDRF 
TgHODI     FRNGACRCLVSSDLFTRGIDIQSVNVVINFDFPKNSETYLHRIGRSGRFGHLGLAINLITYDDRF 
           **:*  * **.***:*******:**********:.:************:****:*****.::**. 
 
DHH1       NLYKIEQELGTEIAAIPATIDKSLYVAENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQ 
CGH-1      TLRRIEQELRTRIEPIPKTVDPKLYVADQQLVDAADETTA------------------------- 
DOZI       NLYKIELELGTEIQPIPNEIDPSIYT--------------------------------------- 
TgHODI     NLYRIESELGTEIQPIPSQIDEAIYT--------------------------------------- 
           .* :** ** *.*  **  :*  :*. 
 
DHH1       QHHPQFMVPPSHQQQQAYPPPQMPSQQGYPPQQEHFMAMPPGQSQPQY 
CGH-1      ------------------------------------------------ 
DOZI       ------------------------------------------------ 
TgHODI     ------------------------------------------------ 
                                                               
Figure 1.5 Sequence alignment of DEAD-box members with the putative TgHoDI 
 The amino acid sequences of Dhh1, CGH-1, DOZI and TgHoDI were aligned 
using the Clustal Omega tool [70]. An asterisk (*) indicates a fully conserved residue, (:) 
indicates strongly similar properties while (.) signifies a weakly conserved residue. 
Conserved motifs are highlighted in grey with motif II (D-E-A-D) in green. 
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 The possibility of TgHoDI to be involved in post-transcriptional gene regulation 
was further suggested in a study by Braun et al. (2010), which attempted to decipher the 
role of Toxoplasma homologue of Argonaute (TgAgo) in RNA silencing. This study 
identified TgHoDI (referred to by its gene ID 583.m00676) as one of four DEAD-box 
RNA helicases that immunoprecipitate with the Argonaut silencing complex [71]. Also, 
studies by Al Riyahi et al. (2006) found that stable knockdown TgAgo clones exhibited 
an impaired ability to silence target gene expression in comparison to wild type parasites; 
thereby identifying the involvement of Ago as a vital component in the double-stranded 
RNA-induced gene silencing in T. gondii [72]. The apparent association of TgHoDI with 
TgAgo, as shown by Braun et al. (2010), may therefore implicate the involvement of 
TgHoDI in post-transcriptional gene regulation in T. gondii. 
1.14 Research Hypothesis and Objectives 
 TgHoDI is hypothesized to be a major player in post-transcriptional gene 
regulation as a central component of mRNPs in Toxoplasma due to its high sequence 
similarity to several vital DEAD-box RNA helicases as well as its involvement within an 
mRNA silencing complex. This study is the first to analyze a specific DEAD-box 
homologue in Toxoplasma. Specifically, the research is aimed at the determination of the 
involvement of TgHoDI in post-transcriptional gene regulation and possible involvement 
in the translational repression of mRNA.  
The specific aims are as follows: 
(i) To examine the genetics and expression profiles of TgHoDI through the use of 
bioinformatic analysis. 
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(ii) Determination of protein function through the analysis of transgenic parasite clones. 
These clones will be used in studies including: 
a) Immunodetection of cellular extracts to determine expression of TgHoDI during 
tachyzoite and bradyzoite stages. 
b) Immunofluorescence analysis for identification of protein localization. 
c) Fluorescent in-situ hybridization for localization with mRNA transcripts. 
d) Colocalization analysis with proteins involved in translational repression. 
e) Determination of alterations in TgHoDI localization as a result of drug treatments. 
 (iii) Complementation studies involving temperature sensitive yeast strains. 
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CHAPTER II - RESULTS 
2.1 Toxoplasma gondii Homologue of DOZI (TgHoDI) 
 DEAD-box RNA helicases have been described as vital components in post-
transcriptional gene regulation in several organisms. In Toxoplasma, a DEAD-box 
member, which has the highest sequence homology to the proteins CGH-1, Dhh1 and 
DOZI, hereby referred to as TgHoDI, was chosen as the subject of this study. This study 
is aimed at determining the presence of mechanisms to regulate gene expression and the 
cytosolic mRNA fate in T. gondii. First, bioinformatic analyses were performed using 
Toxodb.org to uncover essential information pertaining to TgHoDI. The information 
obtained was subsequently used in the design and construction of recombinant TgHoDI 
reporter plasmids.  
 The genomic sequence in the TgHoDI locus spans either 4028bp (type I) or 4037 
bp (type II and III), of all 3 parasite strains on chromosome XI. Within the TgHoDI locus 
5 exons and 4 introns were found, with the 5 exons encoded by a 2073 nucleotide 
sequence which also contains UTRs of 339 and 306 nucleotides at the 5' and 3' ends, 
respectively. The locus of TgHoDI is annotated as Tggt1_089230 for type I, 
TgME49_313010 for type II and TgVeg_097040 for type II parasites [15]. The 
illustration of the genomic sequence and splicing of TgHoDI for type I Toxoplasma, 
which will be used in this study, is shown in Figure 2.1. The genomic sequence which 
spans from 2,642,433 to 2,646,460 on Chr. XI results in a coding sequence (CDS) of 
1428 base pairs and encodes a 475 amino acid protein with a calculated molecular weight 
of 53.462 kDa and an isoelectric point of 8.58. An alignment of the nucleotide and 
corresponding codon sequence for TgHoDI is shown in Figure 2.2. Furthermore, the 
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derived amino acid sequence is 475 amino acids in length and similar in all strains with 
only one amino acid variation observed at the 70th residue (Fig. 2.3, highlighted in red). 
In type I this residue is an asparagine while in type II and III it is a serine. 
 
 
Figure 2.1 Genomic organization of TgHoDI  
 The 1.42 Kb coding sequence of TgHoDI is the result of the splicing of 5 exons 
from the genomic sequence which spans from 2,642,433 to 2,646,460 (4.0 Kb) on 
chromosome XI. Open boxes represent exons in the genomic sequence while introns are 
shown as connector lines. The genomic location of exon flanks is illustrated by values 
above the exon-intron junction; i.e exon 1 spans from 2,645,840 to 2,646,460. 
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  ATGAGCGCAGCCTACTACACCCGCAGACCCGGGCTCTCTGGATCGCCCTATCCCCAGTCTCAAAACGGAAGCGGCGAGAGAAAC 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
M  S  A  A  Y  Y  T  R  R  P  G  L  S  G  S  P  Y  P  Q  S  Q  N  G  S  G  E  R  N 
 
GCGAACCAGGGGCAAGGCCCGGCGCCCTACGGCTACCCGCCTCAGCAGCGCATGCAACACTTCAGTCAGCCTCAAAACAGTGTG 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
A  N  Q  G  Q  G  P  A  P  Y  G  Y  P  P  Q  Q  R  M  Q  H  F  S  Q  P  Q  N  S  V 
 
CCTTCCCAGCCGGCCAACCCCGCGCACGTCGACCCGAACAACAATCCTGAGGGCGACGAAGGCTGGAAAAGCAAAGTCGTCCTG 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
P  S  Q  P  A  N  P  A  H  V  D  P  N  N  N  P  E  G  D  E  G  W  K  S  K  V  V  L 
 
CCTCCAAAGGACAACCGCGTGAAAACCGAGGATGTGACGAAGACGAAAGGCACGGACTTTGAGGAGTATTTTCTACGACGTGAA 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
P  P  K  D  N  R  V  K  T  E  D  V  T  K  T  K  G  T  D  F  E  E  Y  F  L  R  R  E 
 
TTGTTGATGGGCATCTTCGAGAAAGGCTTCGAAAAGCCGTCGCCAATCCAAGAAGCGTCGATTCCAATTGCTCTCGCCGGGAAA 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
L  L  M  G  I  F  E  K  G  F  E  K  P  S  P  I  Q  E  A  S  I  P  I  A  L  A  G  K 
 
AACATCCTCGCTCGGGCGAAAAACGGCACTGGAAAAACCGCCGCGTTCTCGATTCCTCTCCTCGAAAAGTGTCAGACGTCGAAG 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
N  I  L  A  R  A  K  N  G  T  G  K  T  A  A  F  S  I  P  L  L  E  K  C  Q  T  S  K 
 
CGTTACATCCAAGGGCTGATTCTGGTTCCGACCCGTGAGCTGGCGCTGCAGACGAGCGCAGTGGTGAAGGCGATTGGGAAGCAT 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
R  Y  I  Q  G  L  I  L  V  P  T  R  E  L  A  L  Q  T  S  A  V  V  K  A  I  G  K  H 
 
ATGAACGTTCAGTGCATGGTGTCGACGGGAGGCACGAGCCTGCGTGACGATATTATGCGGCTGTACAACCCGGTGCATGTACTC 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
M  N  V  Q  C  M  V  S  T  G  G  T  S  L  R  D  D  I  M  R  L  Y  N  P  V  H  V  L 
 
TGTGGGACGCCGGGAAGAATTCTGGACCTGGCGAACAAGGGTGTCGCAGACTTGAGCAACTGCCATATGGTGGTCATGGACGAA 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
C  G  T  P  G  R  I  L  D  L  A  N  K  G  V  A  D  L  S  N  C  H  M  V  V  M  D  E 
 
GCAGACAAACTGCTCTCGGCGGAGTTTCAACCGATTGTCGAGGAACTCATCAAGTTCGTCCCGCGTGAGAGGCAAATTCTGATG 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
A  D  K  L  L  S  A  E  F  Q  P  I  V  E  E  L  I  K  F  V  P  R  E  R  Q  I  L  M 
 
TACTCCGCGACCTTCCCGGTCACGGTCAAAGACTTCAAACACAAGTACCTGCCAGATGCTCACGAAATCAACCTCATGGACGAA 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
Y  S  A  T  F  P  V  T  V  K  D  F  K  H  K  Y  L  P  D  A  H  E  I  N  L  M  D  E 
 
CTCACGCTCAAGGGTGTCACGCAGTACTACGCCTTCGTCGAAGAACGCCAAAAAGTTCACTGCCTTAACACTCTATTCTCGAAG 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
L  T  L  K  G  V  T  Q  Y  Y  A  F  V  E  E  R  Q  K  V  H  C  L  N  T  L  F  S  K 
 
CTTCAAATCAACCAAGCAATCATTTTCTGCAACAGCGTGACTCGTGTGGAGCTTCTGGCGAAGAAGATCACGGAACTCGGATAC 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
L  Q  I  N  Q  A  I  I  F  C  N  S  V  T  R  V  E  L  L  A  K  K  I  T  E  L  G  Y 
 
TCGTGCTTCTACATCCATGCGCGGATGATGCAGTCCCACAGAAACCGGGTTTTCCACGATTTCCGGAACGGGGCGTGTCGCTGC 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
S  C  F  Y  I  H  A  R  M  M  Q  S  H  R  N  R  V  F  H  D  F  R  N  G  A  C  R  C 
 
CTCGTGTCGTCCGACCTCTTCACACGTGGAATCGACATTCAGTCCGTTAATGTCGTTATCAACTTCGACTTCCCAAAGAACTCT 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
L  V  S  S  D  L  F  T  R  G  I  D  I  Q  S  V  N  V  V  I  N  F  D  F  P  K  N  S 
 
GAGACATATCTGCACCGCATTGGGCGCTCCGGTCGCTTCGGACACCTCGGACTTGCCATCAACCTTATCACTTACGACGACCGT 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
E  T  Y  L  H  R  I  G  R  S  G  R  F  G  H  L  G  L  A  I  N  L  I  T  Y  D  D  R 
 
  TTCAACCTCTACCGAATTGAGAGCGAACTTGGTACCGAAATTCAGCCGATTCCGAGCCAGATTGACGAAGCAATTTAC|ACATAG 
  ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::|:::--- 
   F  N  L  Y  R  I  E  S  E  L  G  T  E  I  Q  P  I  P  S  Q  I  D  E  A  I  Y | T 
 
 
Figure 2.2 Nucleotide and Codon sequence of T. gondii DEAD-Box protein TgHoDI  
  
 Translation of nucleotide coding sequence to the corresponding amino acid 
sequence for TgHoDI. Analyses was performed using Nucleotide Amino Acid Alignment 
(NAP) software. (|) Indicates interruption of ORF prior to last threonine for the addition 
of sequence tags for functional analysis in the study. 
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Type_I     MSAAYYTRRPGLSGSPYPQSQNGSGERNANQGQGPAPYGYPPQQRMQHFSQPQNSVPSQP 
Type_II    MSAAYYTRRPGLSGSPYPQSQNGSGERNANQGQGPAPYGYPPQQRMQHFSQPQNSVPSQP 
Type_III   MSAAYYTRRPGLSGSPYPQSQNGSGERNANQGQGPAPYGYPPQQRMQHFSQPQNSVPSQP 
           ************************************************************ 
 
Type_I     ANPAHVDPNNNPEGDEGWKSKVVLPPKDNRVKTEDVTKTKGTDFEEYFLRRELLMGIFEK 
Type_II    ANPAHVDPNSNPEGDEGWKSKVVLPPKDNRVKTEDVTKTKGTDFEEYFLRRELLMGIFEK 
Type_III   ANPAHVDPNSNPEGDEGWKSKVVLPPKDNRVKTEDVTKTKGTDFEEYFLRRELLMGIFEK 
           *********.************************************************** 
 
Type_I     GFEKPSPIQEASIPIALAGKNILARAKNGTGKTAAFSIPLLEKCQTSKRYIQGLILVPTR 
Type_II    GFEKPSPIQEASIPIALAGKNILARAKNGTGKTAAFSIPLLEKCQTSKRYIQGLILVPTR 
Type_III   GFEKPSPIQEASIPIALAGKNILARAKNGTGKTAAFSIPLLEKCQTSKRYIQGLILVPTR 
           ************************************************************ 
 
Type_I     ELALQTSAVVKAIGKHMNVQCMVSTGGTSLRDDIMRLYNPVHVLCGTPGRILDLANKGVA 
Type_II    ELALQTSAVVKAIGKHMNVQCMVSTGGTSLRDDIMRLYNPVHVLCGTPGRILDLANKGVA 
Type_III   ELALQTSAVVKAIGKHMNVQCMVSTGGTSLRDDIMRLYNPVHVLCGTPGRILDLANKGVA 
           ************************************************************ 
 
Type_I     DLSNCHMVVMDEADKLLSAEFQPIVEELIKFVPRERQILMYSATFPVTVKDFKHKYLPDA 
Type_II    DLSNCHMVVMDEADKLLSAEFQPIVEELIKFVPRERQILMYSATFPVTVKDFKHKYLPDA 
Type_III   DLSNCHMVVMDEADKLLSAEFQPIVEELIKFVPRERQILMYSATFPVTVKDFKHKYLPDA 
           ************************************************************ 
 
Type_I     HEINLMDELTLKGVTQYYAFVEERQKVHCLNTLFSKLQINQAIIFCNSVTRVELLAKKIT 
Type_II    HEINLMDELTLKGVTQYYAFVEERQKVHCLNTLFSKLQINQAIIFCNSVTRVELLAKKIT 
Type_III   HEINLMDELTLKGVTQYYAFVEERQKVHCLNTLFSKLQINQAIIFCNSVTRVELLAKKIT 
           ************************************************************ 
 
Type_I     ELGYSCFYIHARMMQSHRNRVFHDFRNGACRCLVSSDLFTRGIDIQSVNVVINFDFPKNS 
Type_II    ELGYSCFYIHARMMQSHRNRVFHDFRNGACRCLVSSDLFTRGIDIQSVNVVINFDFPKNS 
Type_III   ELGYSCFYIHARMMQSHRNRVFHDFRNGACRCLVSSDLFTRGIDIQSVNVVINFDFPKNS 
           ************************************************************ 
 
   Type_I     ETYLHRIGRSGRFGHLGLAINLITYDDRFNLYRIESELGTEIQPIPSQIDEAIYT 
   Type_II    ETYLHRIGRSGRFGHLGLAINLITYDDRFNLYRIESELGTEIQPIPSQIDEAIYT 
     Type_III   ETYLHRIGRSGRFGHLGLAINLITYDDRFNLYRIESELGTEIQPIPSQIDEAIYT 
              ******************************************************* 
 
Figure 2.3 Amino acid alignment for TgHoDI protein in three T. gondii lineages 
 
 The amino acid sequences of TgHoDI for the three clonal strains of T. gondii 
were aligned using the Clustal Omega tool [70]. An asterisk (*) indicates a fully 
conserved residue, while (.) signifies a weakly conserved residue. Variation in amino acid 
sequences is highlighted in red while putative phosphorylation sites are in grey [14, 15]. 
  
 
 
 
41 
 
 Gene expression profiles revealed mRNA levels of TgHoDI equal in all three 
clonal strains. However, further analysis of mRNA expression levels of TgHoDI for the 
different asexual stages was conducted only in the type II (Me49) clonal strain [15]. Due 
to the high sequence similarity between the three strains, which has been previously 
addressed, the data obtained may be taken as a representation of expression in the type I 
(RH) strain used in this study. The transcript levels remain relatively unaltered during 
intracellular/extracellular conditions as well as during bradyzoite differentiation. 
Furthermore, variation in mRNA expression was only identified in unsporulated oocysts, 
which exhibited a decrease in mRNA levels. 
 Microarray data of all examined samples identified the presence of 110 SNPs, of 
which 106 were synonymous and four non-synonymous, all within the CDS [15]. 
Furthermore, SNP analysis of the three clonal lineages identified the presence of 35 SNPs 
(five in the CDS, two in 5' UTR), only one of which is non-synonymous. Interestingly, no 
identified SNPs were found for analysis of type II and III parasite lineages. This data 
correlates with the high amino acid sequence similarity observed throughout clonal 
strains. Three possible phosphorylation sites were identified through mass-spectrometry 
at serine residues at the 15th, 20th and 24th amino acid position within type I (RH) strain 
(Fig. 2.3). These residues are conserved among the three strains and suggest post-
translational modifications implicated in protein function. A summary of the variations of 
TgHoDI in the three strains are presented in Table 2.1. 
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 Clonal Strain 
Type I (RH) Type II (Me49) Type III (Veg) 
 
ToxoDB Gene ID 
 
 
Tggt1_089230 
 
TgME49_313010 
 
TgVEG_097040 
 
Chromosomal 
location 
 
2,642,433 to 
2,646,460 
(Chromosome: XI) 
 
 
3,032,131 to 
3,036,167 
(Chromosome: XI) 
 
 
3,020,945 to 
3,024,981 
(Chromosome: XI) 
 
 
Genomic Sequence 
Length 
 
 
4028 bp 
 
4037 bp 
 
4037 bp 
 
Coding Sequence 
Length 
 
 
1428 base pairs 
 
Amino Acid 
Composition 
 
 
475 amino acids 
 
Molecular Weight 
 
 
53462 Da 
 
53435 Da 
 
53435 Da 
 
Isoelectric Point 
 
 
8.58 
 
Table 2.1 Summary of Bioinformatic data on TgHoDI in three clonal strains 
  
 Data obtained from ToxoDB database comparing several characteristics of the 
DEAD-box RNA helicase TgHoDI in Toxoplasma [15]. The three clonal strains show 
high sequence similarity at the transcriptional and translational level with almost identical 
coding sequence lengths, amino acid composition and isoelectric points. 
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2.2 Generation of Transgenic Toxoplasma strains expressing recombinant tagged 
TgHoDI at physiological levels 
 To establish a system allowing for the functional study of TgHoDI, we adopted to 
C-terminally tag with (a) a streptavidin-FLAG tag (SF; 21 a.a., 8.42 kDa) and (b) yellow 
fluorescent protein (YFP; 239 a.a, 29.56 kDa). Moreover, to access the level of 
expression at normal physiological levels, the tag sequence was introduced into the 
chromosomal locus by homologous recombination (knock-in) in the ΔKu80 parasite 
strain. This strain was instrumental for the generation of knock-in mutants because the 
Ku80 protein, which functions in non-homologous end-joining pathways, was removed 
and therefore the ΔKu80 strain allows for only homologous recombination [73]. The 
nucleotide sequence encoding the protein tags were inserted prior to the last codon 
(ACA-threonine) in the open reading frame (Fig. 2.2, indicated by |). Due to the fact that 
commercial antibodies against DEAD-box proteins in T. gondii are unavailable, the 
presence of an epitope tag would allow for the immunological studies necessary to 
decipher the possible role of TgHoDI.  
 To isolate and identify parasite clones stably expressing SF and yellow 
fluorescent protein (YFP) PCR analyses for the presence of designed sequences within 
the genomic DNA was performed using four specific oligonucleotide primer sets 
(Appendix B). Two sets of oligonucleotides either (a+b' and b+b') or (a+c and b+c) 
allowed for the confirmation of recombinant genomic sequences for TgHoDI-SF and 
TgHoDI-YFP, respectively (Fig. 2.4). The oligonucleotides (b') and (c) specifically 
amplified the sequences present within the 5' region of the recombinant protein tags and 
provided a means of identification of clones by the amplification of recombinant bands at 
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~3 kb and ~4 kb, corresponding to the introduced nucleotide sequence, which were not 
present in the parental strain (Fig. 2.4). The use of two oligonucleotides (a) and (b) 
upstream within the coding region of TgHoDI allowed for the confirmation of integration 
of recombinant sequences into the genome, rather than transient expression of the 
recombinant plasmid. The combination of these oligonucleotides with the oligonucleotide 
(a'), which targets the 3' region of TgHoDI, were used as internal controls and resulted in 
bands at ~3 kb and ~3.5 kb for both parental and transgenic strains.  
 
Figure 2.4 PCR analysis of transgenic T. gondii strains expressing recombinant 
TgHoDI  
 
 ΔKu80 parasites were genetically modified to contain transgenic sequences 
allowing for the analysis of endogenous TgHoDI protein. (Top) Illustration of transgenic 
and parental genomic sequences with PCR primer binding regions for the three parasite 
clones. (Bottom) PCR analysis for the confirmation of recombinant sequence integration 
into the T. gondii genome. Amplification of bands of ~3 and 4 kb in transgenic clones, 
and not in the parental ΔKu80 strain, confirmed successful tagging of TgHoDI protein. 
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 To monitor the expression of recombinant protein, positive clones and parental 
strains were analyzed using appropriate antisera (Fig. 2.5). When parasite lysates were 
analyzed with α-GFP and α-FLAG antisera, bands were observed at ~83.0 kDa and ~61.9 
kDa corresponding to the expected sizes for TgHoDI-YFP and TgHoDI-SF protein, 
respectively (Fig. 2.5). Lactate dehydrogenase-1, ~35 kDa, was used as a loading control 
in the analyses. This data confirms the expression of recombinant protein and supports 
the results obtained from PCR analyses. 
 
Figure 2.5 Western blot analysis for confirmation of transgenic TgHoDI protein 
 
 Immunoblot of stable transgenic strains expressing TgHoDI-SF and TgHoDI-YFP 
protein. The presence of bands at ~61.9 and 80.0 kDa in transgenic strains, and not the 
parental ΔKu80, confirm successful expression of recombinant TgHoDI-SF and TgHoDI-
YFP, respectively. Antisera against lactate dehydrogenase-1, ~35 kDa, was used as a 
loading control for analyses.  
 
2.3 Gross analysis for newly generated parasite strains in comparison to the 
parental ΔKu80 strain 
 2.3.1 Doubling time 
 To determine the effects of recombinant tagged protein on the growth of T. gondii 
parasites, transgenic clones were analyzed in comparison to the parental ΔKu80 strain. 
Equivalent number of parasites were allowed to infect HFF monolayers and growth was 
analyzed for various periods. The number of parasites in a total of 100 vacuoles were 
counted per study, with analyses performed in triplicate for each of the three clones. After 
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24 hours it was observed that transgenic and parental clones exhibited similar replication 
patterns with almost half of the total number of vacuoles containing eight parasites (Fig. 
2.6). Approximately 50.3% of ΔKu80 parental vacuoles, 45.7% of SF-tagged and 45.0% 
of YFP-tagged clones contained 8 parasites. This gives an average doubling time of 
approximately 8 hours for all monitored clones, which is similar to previously reported 
values [1]. Similarly, after 36 hours almost half of the total vacuoles analyzed contained 
16 parasites, reinforcing the approximation of an 8 hour doubling time. At 36 hours, 
approximately 50.7% of ΔKu80 parental vacuoles, 46.3% of SF-tagged and 46.7% of 
YFP-tagged clones contained 16 parasites. The similarity in parasite growth when 
comparing transgenic and parental strains demonstrates that the addition of protein tags 
had minimal effect on the ability of transgenic parasites to duplicate. 
 2.3.2 General protein expression 
  
 To determine if the addition of protein tags altered parasite phenotypes, the 
expression of LDH1 was used to monitor variations in parasite metabolic processes for 
tachyzoite transgenic strains (Fig. 2.7). The level of expression was analyzed as a 
percentage of α-tubulin (Tub) expression. α-Tubulin is a structural component of the 
parasite and therefore was used as a baseline for comparison. For the parental ΔKu80 
strain, the relative expression of LDH1 was found to be ~93.6% with SF and YFP strains 
exhibiting relative expression values of ~91.1 and 81.6%, respectively. These variations 
of 2% and 12%, for SF and YFP respectively, indicate minimal variation in metabolic 
processes for the transgenic strains. Furthermore, these values indicate that the size of the 
tag does not greatly influence the cellular phenotype of the parasites. 
 
47 
 
 
Figure 2.6 Growth analysis of transgenic and parental clones at 24 and 36 hours. 
 Parental (ΔKu80) and transgenic strains were allowed to infect HFF monolayers 
and the number of parasites were counted per vacuole 24 and 36 hr post-infection. At 24 
hours, vacuoles for both parental and transgenic clones were found to contain 8 parasites. 
At 36 hours post-infection, the majority of vacuoles contained 16 parasites. Analyses 
were performed in triplicate with standard deviation shown (error bars).  
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 2.3.3 Ability to differentiate 
 The addition of tags could alter the ability of parasites to undergo tachyzoite to 
bradyzoite differentiation. We thus used a three day CO2 starvation and alkaline 
treatment protocol to induce differentiation of newly generated clones in comparison to 
the parental. Three days post-infection, parasite cultures were harvested and Western blot 
analyses performed. Antisera against BAG1 were used to determine parasites 
differentiation to the bradyzoite stage. Once again, expression of BAG1 was compared to 
the level of Tub expression. Parental ΔKu80 parasites were found to have a relative 
expression of ~26.4% while transgenic SF and YFP clones exhibited levels of ~59.7% 
and 64.1% (Fig. 2.7). This translates into a 2.26 and 2.46 times increase in BAG1 
expression for SF and YFP strains in comparison to the parental strain, indicating an 
overall increase in bradyzoite differentiation for transgenic clonal parasites.  
 To compare the TgHoDI levels between the two asexual stages of Toxoplasma, 
the relative expression of recombinant protein was analyzed as a percentage of α-tubulin 
in tachyzoite and bradyzoite stages. In tachyzoite parasites, SF and YFP transgenic clones 
exhibited relative expression levels of 83.9% and 83.4%, respectively. In comparison, 
bradyzoite parasites were found to express relative TgHoDI levels of 58.3% and 60.7% 
for SF and YFP transgenic clones, respectively (Fig 2.7). For tachyzoite parasites there is 
a calculated 1.43 and 1.37 time increase in TgHoDI expression for the SF and YFP 
clones when compared to their counterparts in the bradyzoite stage. Due to the lack of 
commercial antisera against endogenous TgHoDI, expression levels could not be 
compared to the wild type ΔKu80 strain.  
 
49 
 
 
 
Figure 2.7 Comparative protein expression for determination of possible phenotypic 
variations between transgenic and parental Toxoplasma strains 
 
 Parasite lysates were subjected to Western blot analysis and subsequent 
densitometric analysis to determine the affects of adding a protein tag on parasite cellular 
processes. Protein densities were compared as relative levels with the structural protein α- 
tubulin as the baseline for analyses. LDH1 levels are not effected in transgenic clones 
while bradyzoite differentiation appears to be amplified in these parasite strains. Studies 
were performed in triplicate with error bars representing standard deviation obtained. 
Statistical analysis was performed via two-tailed student t-test with p<0.05 with (*) 
indicating significant variation among analyzed samples. 
 
 
 
 
 
 
 
 
 
 
 
50 
 
2.4 Attempt to control the level of TgHoDI via ligand induced degradation 
 To determine the function of TgHoDI in Toxoplasma, it was necessary to develop 
a system to alter the level of TgHoDI protein. Phenotypic variations could then be 
monitored as a function of changes in protein level and function. To establish a system 
for functional studies, TgHoDI was fused to a ligand-controlled destabilizing domain 
(ddFKBP, 20.75 kDa). This system provides rapid, reversible and fine-tuned regulation 
of protein levels due to selective stabilization of the tagged protein by the reversible 
binding of a synthetic ligand, referred to as Shield-1. In the absence of ligand, the 
ddFKBP causes degradation of tagged protein because of an inherited instability 
conferred by the fusion protein from the ddFKBP. The addition of a synthetic ligand 
stabilizes the ddFKBP and shields it from degradation [74]. The coding sequence of 
ddFKBP was induced between streptavidin and FLAG to allow the read through 
translation to give TgHoDI-strep-ddFKBP-FLAG (Fig. 2.8). As with previous 
recombinant proteins constructed in this study, the tag sequence was introduced into the 
locus within the parental ΔKu80 parasite strain, resulting in a C-terminally tagged fusion 
protein (Fig. 2.8).  
 To identify parasite clones stably expressing tagged protein, positive clonal 
parasites were analyzed using appropriate antisera (Fig. 2.8). Analysis of parasite lysates 
with α-FLAG antisera revealed a single band at 74.20 kDa corresponding to the expected 
sizes for TgHoDI-DDSF (Fig. 2.8). Tub, 50.11 kDa, was used as a loading control in the 
analyses with TgHoDI-SF (61.9 kDa) as a positive control. This data confirms the 
expression of recombinant protein in transgenic clonal Toxoplasma strains.  
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 To determine if the fusion of ddFKBP to TgHoDI allowed for fine-tuned 
manipulation of protein expression, the confirmed transgenic clones were first analyzed 
in the presence and absence of Shield-1 ligand (1 µM). For this preliminary experiment, 
transgenic parasites, which were sub-cultured previously in media containing Shield-1, 
were grown in the absence of ligand for 2 passages (~4 days) and parasite lysates were 
subjected to Western blot analysis. The Antisera against α-FLAG revealed bands 
corresponding to TgHoDI-DDSF in both treated and untreated samples (Fig. 2.9). This 
demonstrated the inability of the ddFKBP to destabilize and cause subsequent 
degradation, of the recombinant protein. TgHoDI-SF was once again used as a positive 
control. As conducted previously, the relative density of recombinant proteins was 
compared as a percentage of α-Tubulin expression. It was observed that the absence of 
Shield-1 had little effect on the expression TgHoDI-DDSF protein, as demonstrated by 
relative densities of 66.5% and 63.1% for treated and untreated parasites, respectively. 
Furthermore, these values are comparable to those obtained for the TgHoDI-SF clones 
(59.9%) in the study. The results obtained demonstrate an inability of the C- terminally 
fused ddFKBP to destabilize TgHoDI protein. However, this inability to alter protein 
levels, which may be attributed to the C- terminal placement of the destabilizing domain 
on TgHoDI, may hint to protein function in cellular processes. Unfortunately, the results 
obtained indicate that the destabilizing domain system cannot be used for subsequent 
phenotypic analysis for variations of protein expression. 
 
52 
 
 
Figure 2.8 Confirmation of transgenic TgHoDI-DDSF protein 
 
 ΔKu80 parasites were modified to express a TgHoDI-DDSF fusion protein for the 
manipulation of protein expression. (Top) Illustration of transgenic coding sequence of 
TgHoDI-DDSF with ddFKBP flanked by streptavidin and FLAG tags on the N- and C- 
terminus, respectively. (Bottom) Immunoblot of stable transgenic strains expressing 
TgHoDI-DDSF protein. Antisera against FLAG identified the presence of a single band 
at 74.2 kDa in two transgenic clones (1 and 2) confirm successful expression of 
recombinant protein. TgHoDI-SF, 61.9 kDa, was used as a positive control. Antisera 
against α-tubulin, 50 kDa, was used as a loading control for analyses.  
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 Figure 2.9 Analysis of transgenic TgHoDI expression in the absence of Shield-1  
 
 Transgenic parasite lysates were subjected to Western blot and subsequent 
densitometric analysis to determine the ability of Shield-1 ligand to stabilize recombinant 
protein. (Top) Western blot of TgHoDI-DDSF stable clones in the presence and absence 
of Shield-1 at increasing protein concentrations (right to left). TgHoDI-SF was used as a 
positive control for the analyses. (Bottom) Densitometric analyses of recombinant protein 
levels as a function of α-tubulin expression. The absence of Shield-1 does not cause the 
destabilization of TgHoDI, thereby exhibiting an inability to control protein expression.  
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2.5 Cellular localization of transgenic TgHoDI-SF 
 To decipher the role of TgHoDI in Toxoplasma, immunofluorescence assays 
(IFA) were performed to determine the cellular localization of TgHoDI protein utilizing 
transgenic clones expressing TgHoDI-SF. The localization of TgHoDI will assist in 
analysis of protein function by revealing cytoplasmic or nuclear association in the 
parasites. Dhh1 and DOZI, TgHoDI homologues, which function in translational 
repression, were found to localize within cytoplasmic mRNP granules. It is necessary to 
determine if TgHoDI exhibits comparable cellular localization, which may imply 
similarities in cellular function. Intracellular transgenic tachyzoite parasites expressing 
TgHoDI-SF protein displayed perinuclear labeling with a granular pattern dispersed 
throughout the cytoplasm (Fig. 2.10). Extracellular parasites showed a distinct pattern 
with highly localized foci of TgHoDI-SF protein (Fig. 2.10). Numerous foci are observed 
throughout the parasite cytoplasm, however it appears that distinct aggregates are present 
at the apical end of the parasites. These observations vary significantly from those for 
intracellular tachyzoites where TgHoDI appears dispersed throughout the cytoplasm. 
Furthermore, distinct aggregates appear to be localized surrounding the nucleus, which is 
not observed in intracellular parasites. Interestingly, these results coincide with 
previously described observations of cytoplasmic granules induced in extracellular 
parasites as a response to environmental stress [75]. Bradyzoite parasites displayed a 
granular cytoplasmic localization, similar to intracellular tachyzoite parasites, however 
distinct foci were also observed at the basal end of the parasites (Fig. 2.10). Furthermore, 
cytoplasmic foci appear to be larger than their counterparts in intracellular tachyzoite 
parasites.  
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Figure 2.10 TgHoDI localizes to the cytoplasm in intra- and extracellular 
Toxoplasma 
 
 Immunofluorescence assay of transgenic T. gondii clone expressing TgHoDI-SF. 
Parasites were immunostained with anti-FLAG and Rhodamine anti-mouse for detection 
of TgHoDI-SF (red) and nuclear staining was performed with Hoechst (blue). (Upper 
panel) Intracellular transgenic tachyzoite parasites display perinuclear labeling with a 
granular pattern dispersed throughout the cytoplasm. (Middle panel) Extracellular 
parasites showed a distinct pattern with highly localized foci of TgHoDI surrounding the 
nucleus. (Lower panel) Intracellular bradyzoite parasites display a granular cytoplasmic 
localization with large aggregates at the basal end of parasites. Images were acquired 
using a 100x oil objective. Scale bars represent 5 µm. 
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2.6 Fluorescent YFP-tag as an alternative to IFA for the localization of TgHoDI 
 The utilization of a fluorescently labeled protein would remove the necessity to 
perform IFA targeting TgHoDI protein. This in turn would simplify analyses by 
minimizing manipulation of samples and removing the need of multiple fluorescent 
antigens for ensuing colocalization studies. However, the fusion of a yellow fluorescent 
protein tag contributes an additional 21 kDa to the recombinant protein, therefore it is 
necessary to ensure that cellular localization is not altered. In comparison to TgHoDI-SF 
transgenic clones, TgHoDI-YFP intracellular tachyzoite parasites exhibit the same 
perinuclear granular cytoplasmic localization (Fig. 2.11). TgHoDI-YFP appears widely 
dispersed throughout the cytoplasm while being excluded from the nucleus. Furthermore, 
the highly localized protein aggregates were observed for the extracellular parasites, with 
distinct foci present at the apical ends and surrounding the nucleus (Fig. 2.11). These 
results are similar to those obtained for the TgHoDI-SF transgenic clonal parasites. The 
cellular localization of TgHoDI-YFP for the intracellular bradyzoite parasites, appears to 
be a combination of both intra- and extracellular phenotypes. Although there are several 
distinct aggregates of protein at the basal end, TgHoDI also appears to be dispersed 
throughout the cytoplasm in smaller granular aggregates (Fig. 2.11). These observations 
imply that in comparison to the SF transgenic clones, the additional size attributed by the 
increased molecular weight YFP-tag does not alter the cellular localization of TgHoDI, 
therefore enabling the use of this transgenic clone in further functional studies. 
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Figure 2.11 Addition of YFP does not alter TgHoDI localization 
 
 Fluorescent microscopy of transgenic T. gondii clone expressing TgHoDI-YFP 
(yellow). After fixation, parasite nuclei were stained with Hoechst (blue)and imaged. 
(Upper panel) Intracellular transgenic tachyzoite display the same perinuclear granular 
localization of TgHoDI protein, as seen previously with TgHoDI-SF. (Middle panel) 
Extracellular parasites display highly localized foci of TgHoDI surrounding the nucleus 
and at the apical parasitic end. (Lower panel) Intracellular bradyzoite parasites exhibit 
granular cytoplasmic TgHoDI localization with large aggregates at the basal end of 
parasites. Images were acquired using a 100x oil objective. Scale bars represent 5 µm. 
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2.7 TgHoDI colocalizes with mRNA granules in extracellular Toxoplasma 
 To determine the possible involvement of TgHoDI in the formation of subcellular 
structures important to cytosolic mRNA fate, it was necessary to identify the location of 
TgHoDI in correlation to mRNA and subcellular structures. In S. cerevisiae Dhh1 has 
been shown to colocalize with cytoplasmic mRNA granules after induced environmental 
stress such as glucose deprivation [66]. As previously described by Lirussi et al. (2011), 
mRNA granules have been found to localize in punctate aggregates within the cytoplasm 
of extracellular parasites [75]. These aggregates are proposed to play a role in stress 
response and the translational repression of target transcripts [75].  
 Fluorescent in-situ hybridization (FISH) was performed on extracellular TgHoDI-
YFP transgenic parasites using an oligo-dT-biotin probe which was subsequently 
conjugated to streptavidin-Rhodamine. In the extracellular parasites, mRNA appears to 
be dispersed throughout the parasite with a granular pattern observed (Fig. 2.12). Several 
distinct foci of mRNA aggregates appear within the cytoplasm surrounding the nucleus. 
These results are in agreement with the previous study by Lirussi et al. (2011) which 
identified distinct mRNA foci within the cytoplasm. TgHoDI-YFP localizes to distinct 
cytoplasmic aggregates excluded from the nucleus (Fig. 2.12). TgHoDI appears to 
colocalize with the mRNA granules at several distinct foci within the cytoplasm (as 
indicated by arrows) (Fig. 2.12). The colocalization of TgHoDI with these mRNA 
granules indicate the possible involvement in cytoplasmic regulation of mRNA. It is 
necessary to further verify whether TgHoDI is involved in regulation by means of 
translational repression or mRNA turnover. 
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Figure 2.12 TgHoDI colocalizes with mRNA granules in extracellular Toxoplasma 
 Fluorescent in-situ hybridization was performed extracellular parasite transgenic 
clone expressing TgHoDI-YFP (false coloured green). mRNA was targeted using oligo-
dT-biotin which was subsequently conjugated to streptavidin-Rho (red). TgHoDI 
localizes to distinct subcellular foci while mRNA displays a granular localization 
throughout the cytoplasm. TgHoDI appears to colocalize with mRNA foci at the apical 
parasitic end as well as other aggregates in the cytoplasm (as indicated by arrows). 
Images were acquired using a 100x oil objective. Scale bars represent 5 µm. 
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2.8 TgHoDI colocalizes with the Stress Granule Marker PABPC3 
 The observation that in extracellular parasites TgHoDI colocalizes with mRNA 
granules led us to identify whether these structures are involved in mRNA degradation or 
translational repression. IFA analysis was employed to identify if TgHoDI colocalizes 
with poly(A) binding protein cytoplasmic-3 (PABPC3). Under normal cellular 
conditions, PABPs isoforms (i.e PABPC1, PABPC3) bind to the poly(A) tails of mRNA 
and regulates protein translation and mRNA stability [42]. Under environmental stresses, 
such as oxidative stress or heat shock, translational arrest is triggered, initiating the 
disassembly of polysomes [28]. Many proteins involved in normal processing events, 
such as PABPs, would assume emergency functions and become associated to subcellular 
aggregates known as stress granules [42]. As a result, proteins such as PABPC3 can be 
employed as markers to identify SGs under induced stresses [42]. Lirussi et al. (2011) 
showed an increase in cytoplasmic mRNA granules as a result of chemically induced 
stress [75]. These granules were also shown to contain aggregates of PABP. Therefore, it 
can be inferred that the mRNA aggregates observed (Fig. 2.11) are stress granules caused 
by the stalling of translational machinery, rather than sites for mRNA turnover.  
 When IFA was performed on extracellular parasites using antisera against 
PABPC3 in the transgenic TgHoDI-YFP strain, PABPC3 appears to be localized 
throughout the parasite. Several distinct foci appear dispersed throughout the cytoplasm 
with a large aggregate present at the basal parasitic end (Fig. 2.13). The localization of 
PABPC3 mimics that of total cellular mRNA previously observed (Fig. 2.13). Once 
again, TgHoDI-YFP appears to localize specifically within aggregates in the cytoplasm. 
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As observed for mRNA colocalization, there were several areas of colocalization between 
TgHoDI and PABPC3 (as indicated by arrows) (Fig. 2.13).  
 To verify the results obtained from fluorescent microscopy, which identifies the 
colocalization of TgHoDI with PABPC3 within these mRNA granules, confocal 
microscopy was employed. Confocal microscopy allows for a higher resolution as well as 
the ability to control the depth of field for acquired images. As expected, the 
colocalization of TgHoDI with PABPC3 is observed at distinct foci within the cytoplasm 
(Fig. 2.13). This further confirms the colocalization of TgHoDI with PABPC3 
implicating TgHoDI as a component in stress granules. Therefore, it can be inferred that 
TgHoDI may function in the translational repression of transcripts in extracellular 
parasites during stress response.  
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Figure 2.13 TgHoDI colocalizes with PABPC3 in extracellular Toxoplasma 
 Immunofluorescence analysis was performed on the extracellular parasite 
transgenic clone expressing TgHoDI-YFP (false coloured green). (Upper panel) 
Fluorescent imaging of antisera against PABPC3 (red) exhibits a granular localization 
throughout the cytoplasm with distinct foci at the basal parasitic end. TgHoDI appears to 
colocalize with PABPC3 at the apical parasitic end as well as other aggregates in the 
cytoplasm (as indicated by arrows). (Lower panel) Confocal imaging of extracellular 
parasites verify the colocalization observed with traditional fluorescent microscopy. 
Fluorescent microscopy images were acquired using a 100x oil objective, with confocal 
images obtained with 63x oil objective. Scale bars represent 5 µm. 
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2.9 TgHoDI aggregates in extracellular Toxoplasma under Oxidative Stress 
 To determine if TgHoDI participates in stress response and is a member of RNPs 
formed under stress conditions, two chemicals, cycloheximide and arsenite were utilized 
for extracellular parasites. Cycloheximide treatment has been shown to prevent stress 
granule assembly and promote the disassembly of pre-formed stress granules [76]. 
Cycloheximide inhibits translational elongation and traps mRNPs into the polysome 
structure, thereby preventing the translocation of mRNA into stress granules [77, 78]. 
Lirussi et al. (2011) showed that arsenite treatment of extracellular parasites resulted in 
increased mRNA granule formation [75]. Arsenite induces oxidative stress which results 
in inhibition of translation and subsequent increase in granule formation [78]. 
 To determine whether the granule structures in Toxoplasma can be influenced by 
cycloheximide treatment, extracellular TgHoDI-YFP parasites were treated with 
cycloheximide (50 µg/mL) for one hour. Parasites were subsequently analyzed using 
FISH targeting total cellular mRNA or IFA employing antibodies against PABPC3. After 
cycloheximide treatment, TgHoDI no longer appears to form cytoplasmic foci and is now 
dispersed throughout the cytoplasm (Fig. 2.14, center panels). For both mRNA and 
PABPC3, cycloheximide treatment appears to have a minimal effect, with the dispersed 
granular localization observed again. As previously observed for the control parasites, 
TgHoDI localized to distinct foci in the cytoplasm (Fig. 2.14, left panels). Both PABPC3 
and mRNA appear dispersed throughout the parasite with several granular aggregates 
observed. An overlay of TgHoDI with either PABPC3 or mRNA exhibit identical results 
as previously observed with several distinct areas of colocalization.  
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 To determine the effect of arsenite to induce granule formation, extracellular 
Toxoplasma parasites were treated with sodium arsenite (10 µM) for one hour. Once 
again, parasites were analyzed using FISH targeting total cellular mRNA and IFA 
employing antibodies against PABPC3. In comparison to the control, extracellular 
parasites treated with arsenite exhibited an increase in the size and number of TgHoDI 
aggregates within the cytoplasm (Fig. 2.14, right panels). An increase in the abundance 
of mRNA granules is observed dispersed throughout the parasite. This observation is in 
agreement with a previously described study by Lirussi et al. (2011) identifying the 
effects of drug treatments on mRNA granule formation in Toxoplasma [75]. Interestingly, 
PABPC3 does not exhibit the same drastic increase in aggregate size and number as seen 
for both TgHoDI and mRNA (Fig. 2.14). Overlay images of TgHoDI with either 
PABPC3 or mRNA exhibit similar areas of colocalization as previously observed, 
indicating involvement of TgHoDI in these mRNPs (Fig. 2.14). These observations 
demonstrate that TgHoDI is a component of stress induced granules in Toxoplasma and 
therefore may be a vital component in post-transcriptional gene regulation. 
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Figure 2.14 Treatment of extracellular parasites with chemical agents alters 
TgHoDI localization 
 
 IFA and FISH were performed on the extracellular parasite transgenic clone 
expressing TgHoDI-YFP (false coloured green). (Upper) Fluorescent imaging of antisera 
against PABPC3 and oligo-dT (red) for control parasites. TgHoDI-YFP extracellular 
parasites were treated with cycloheximide (50 mg/mL) (middle panels) or sodium m-
arsenite (10 µM) (lower panels). Addition of drug treatments appear to alter cellular 
localization of TgHoDI. Images were acquired using a 100x oil objective. Scale bars 
represent 5 µm. 
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2.10 TgHoDI functionally complements Δdhh1 in S. cerevisiae 
 To evaluate whether TgHoDI could possess a comparable function as Dhh1, we 
sought to determine whether TgHoDI could complement the temperature sensitive (TS
-
) 
phenotype exhibited by Δdhh1 S. cerevisiae strains. In yeast, Dhh1 functions in mRNP 
remodeling during mRNA decay by interaction with target transcripts leading to 
activation of decapping [68]. Furthermore, under glucose deprivation Δdhh1 cells 
exhibited a reduction in stress granule formation, indicating its possible role in 
translational repression during environmental stress [67]. Knock-out studies by Chang et 
al. (2003) identified Dhh1 as a non-essential protein in yeast viability, however Δdhh1 
strains exhibited impaired growth at both 30
o
C and 37
o
C [65]. The sequence similarity 
between Dhh1 and TgHoDI (69% identity) lead to the analysis of complementation 
experiments which may shed light on the physiological function of TgHoDI in 
Toxoplasma.  
 The Δdhh1strain showed a TS- phenotype at both 30o and 37oC in comparison to 
wild-type (wt) which coincides with previously described observations (Fig. 2.15) [65]. 
The growth defect is seen to a greater extent for analyses conducted for 24 hours in 
comparison to the 48 hour time point (Fig. 2.15). ΔDhh1 cells transformed with empty 
plasmid (negative control) showed identical growth to the non-treated Δdhh1 strain 
confirming the inability of parental vector to alter cell growth (Fig. 2.15). For the 
expression of Dhh1, cells were transformed with a low copy centromeric plasmid 
expressing Dhh1 from its endogenous promoter. At 24 hours, transformed cells were able 
to completely rescue the TS
-
 phenotype. Cells exhibited growth similar to the wt yeast 
strains at both 30
o
 and 37
o
C and the rescued phenotype was further exemplified after 48 
hours in which transformed cells exhibited large colonies (Fig. 2.15).  
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 To express TgHoDI in yeast, cells were transformed with a high copy number 
plasmid (2µm) expressing TgHoDI under the strong yeast GPD promoter. After 24 hours, 
transformed Δdhh1cells exhibited a partially rescued TS- phenotype at both 30o and 37oC 
in comparison to wt and Dhh1 complemented strains (Fig. 2.15). At 48 hours the ability 
of TgHoDI to compliment the TS
-
 was better observed as indicated by larger yeast 
colonies. Although the phenotypic rescue was observed at both temperatures, the ability 
of TgHoDI to complement yeast growth was observed to a greater extent at 30
o
C. In 
comparison to cells transformed with Dhh1, phenotypic complementation with TgHoDI 
appears to occur to a lesser extent, with fewer, smaller colonies observed. Taken together, 
these results suggest that TgHoDI may act as a functional homologue to Dhh1 in stress 
response. However, the deviation in TgHoDI's ability to complement growth to wild type 
levels, in comparison to Dhh1, leaves open the possibility that TgHoDI functions in a 
similar but non-identical manner to Dhh1 in yeast. 
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Figure 2.15 Expression of TgHoDI complements TS
-
 phenotype of Δdhh1 yeast 
strain 
 Δdhh1 yeast strains were transformed with either an empty vector, Dhh1 or 
TgHoDI for complementation of TS
-
 growth defect. (Upper panel)At 24 hours, Dhh1 was 
able to restore growth to wt levels at both 30
o
 and 37
o
C. At both temperatures, TgHoDI 
partially complements the growth defect of Δdhh1 as demonstrated by smaller colony 
sizes in comparison to wt.(Lower panel) After 48 hours, Dhh1 is observed to fully 
complement the phenotypic growth defect at both temperatures.  
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CHAPTER III- DISCUSSION 
 TgHoDI belongs to the highly conserved DEAD-box RNA helicases which 
includes the C. elegans CGH-1, S. cerevisiae Dhh1 and P. berghei DOZI [65, 67, 68]. 
Over the past several decades, members of this protein family have been implicated in a 
diverse collection of cellular functions ranging from nuclear mRNA export to post-
transcriptional gene regulation [55]. Knock-out studies have linked these proteins to a 
decrease in organism viability with major changes in cellular pathways involved in stress 
response and mRNP formation [65, 68]. The presence of these proteins in mRNPs in such 
an array of organisms indicates the involvement of these proteins as evolutionarily 
conserved components of mRNPs which function in the stability and storage of mRNAs. 
The current study is aimed to determine the possible involvement of TgHoDI in post-
transcriptional gene regulation in T. gondii.  
 Bioinformatic analysis of TgHoDI indicated the importance of its expression to 
parasite viability. The 1428 bp coding sequence of TgHoDI encodes a 475 amino acids 
with a molecular weight of 53.46 kDa. Nine highly characterized motifs of the DEAD-
box RNA helicase family were identified in TgHoDI, validating its classification within 
this subfamily (Fig. 3.1). The amino acid sequence is conserved among the three clonal 
lineages with only one residue difference observed (Fig 3.1). The asparagine residue in 
type I is changed to a serine for both type II and III strains. Whether this variation may be 
implicated in a altered protein structure or function was not deduced in the current study. 
However, the presence of a single amino acid difference suggests a necessary 
conservation in protein structure and function. Minimal variations in TgHoDI mRNA 
levels during intracellular/extracellular conditions as well as during bradyzoite 
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differentiation indicate its expression is required throughout the various stages of the 
parasite life cycle. The increase in mRNA levels during oocyst sporulation may suggest 
an additional role in oocyst development. TgHoDI mRNA levels were found to increase 
four days into sporulation and remain elevated for the remainder of the parasitic life 
cycle. Therefore, the expression of TgHoDI during early sporulation may be necessary 
for the regulation of transcripts throughout the remainder of this developmental stage. 
The DEAD-box RNA helicase DOZI in Plasmodium was found to be vital for the 
translational repression and regulation of developmental mRNAs throughout the early 
stages of zygote development [68]. This may suggest that TgHoDI functions similarly in 
mRNA regulation during oocyst development as DOZI in zygote maturation. 
 Three conserved serine phosphorylation sites are present in the N-terminal 
extension, indicating the possibility of post-transcriptional modifications (Fig. 3.1). The 
presence of these sites in the N-terminal extension, which is known to play a role in 
DEAD-box RNA helicase specificity and cellular function, may indicate the involvement 
of post-translational modification in protein function. Similar phosphorylation sites have 
been identified for other DEAD-box helicases, such as Dhh1, however the role of these 
sites in post-translational modification and protein function have yet to be determined 
[79]. Furthermore, in eukaryotes, including Toxoplasma and Plasmodium, the 
phosphorylation of eIF2α is a conserved mechanism of stress response which represses 
global protein synthesis and enhances formation of cytoplasmic mRNA granules [80]. 
This opens the possibility that similar phosphorylation mechanisms may be acting on 
TgHoDI during cellular responses thereby altering cellular function. 
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Figure 3.1 Summary of bioinformatic data pertaining to TgHoDI amino acid 
sequence 
 The amino acid sequence of TgHoDI contains the highly characterized DEAD-
box motifs (highlighted in grey). Conserved sequences for these motifs is shown (Top). 
The three phosphorylation sites believed to be involved in functional modifications are 
identified on serine residues 15, 20 and 25. The single amino acid variation among the 
three clonal lineages is present at residue 70 (highlighted in green). Introduction of 
epitope tags was performed prior to the last threonine residue (shown by *). 
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 The transgenic TgHoDI-SG and TgHoDI-YFP strains exhibited similar doubling 
time in comparison to the parental strain, which showed an approximate replication time 
of approximately 8 hours for the two transgenic clones, indicating that the introduction of 
epitope tag sequences did not hinder parasite replication. However, some variation in 
tachyzoite metabolism was identified when protein levels of LDH-1 were analyzed. Also, 
the levels of BAG1, a bradyzoite stage-specific marker, was induced in both SF and YFP 
transgenic clones (Fig 2.7). The change of BAG1 expression, which was found to be 
statistically significant, suggests that the addition of a C-terminal tag may interfere with 
the downstream activity of TgHoDI during bradyzoite conditions (Fig. 3.1, indicated by 
*). Linder et al. (2011) identified the importance of N- and C- terminal extensions of 
DEAD-box RNA helicases for mRNA-protein and protein-protein interactions [55]. The 
addition of protein tags of ~8.4 and ~29.6 kDa, for SF and YFP respectively, may 
interfere with the ability of TgHoDI to interact with its partner(s). Such interactions 
become vital when the parasite was exposed to stress conditions, i.e. bradyzoite growth, 
whereas such conditions were not found in the tachyzoite growth condition. Thus, no 
detrimental effect of the protein tags was observed under the tachyzoite conditions. 
 In the attempt to determine the possible function of TgHoDI, knockdown studies 
utilizing the destabilizing domain system was employed. However, the addition of the 
destabilizing domain (ddFKBP) failed to induce TgHoDI degradation (Fig. 2.9). This 
inability to induce degradation indicates that the C- terminal region of TgHoDI may be 
involved in protein-protein interactions, thereby shielding the ddFKBP from degradation 
machinery. For future work, an alternative method that allows for the successful down 
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regulation of TgHoDI expression would give a better understanding of protein function 
and this mode of gene regulation. 
 Both transgenic strains, TgHoDI-SF and TgHoDI-YFP, showed similar cellular 
localization, which indicates that epitope tag size has minimal effect on protein 
localization. Also, Huynh and Carruthers (2009) showed that this knock-in of SF or YFP 
tags at the native locus of a gene does not alter the location of the gene products [73]. The 
absence of TgHoDI in the nucleus in all life stages may suggest its primary function in 
the cytoplasm. The punctate cytoplasmic localization observed in both extracellular 
tachyzoite and intracellular bradyzoite parasites mimics those previously described for 
both Dhh1 and DOZI [65, 68]. Furthermore, mRNA granules have been recently 
observed in extracellular parasites are associated with increased parasite viability [75]. In 
comparison to bradyzoite parasites, the presence of very distinct cellular foci of TgHoDI 
in extracellular Toxoplasma may indicate a variable stress response mechanism during 
bradyzoite differentiation. In the bradyzoite stage, the localization of TgHoDI appears to 
be between extra- and intracellular tachyzoite localization. Therefore, this may suggest 
that under bradyzoite conditions the localization of TgHoDI was altered due to stress 
response and that the location of TgHoDI reflects the dynamic of tachyzoite to bradyzoite 
differentiation. 
 Mair et al. (2006) described the interaction of DOZI with 92 transcripts, thereby 
validating its role in translational repression in Plasmodium [68]. In extracellular 
tachyzoites, several distinct areas of colocalization were observed for TgHoDI with 
mRNAs which indicates the interaction between the two (Fig. 2.12). This study is the 
first to show that TgHoDI is an important component in post-transcriptional gene 
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regulation. In agreement with this, the study by Braun et al. (2010) identified TgHoDI 
(referred to as 583.m00676) as a member of the TgAgo complex which was subsequently 
implicated in RNA-induced gene silencing [71, 72]. However, the incomplete 
colocalization of TgHoDI aggregates with mRNAs, which is prominent at the basal 
parasitic end, suggests that there is a second protein function which has yet to be 
identified. 
 Colocalization of TgHoDI and mRNA granules suggests a possible function of 
TgHoDI in post-transcriptional regulation. Therefore it is necessary to determine 
TgHoDI's involvement in mRNA fate. DEAD-box RNA helicases are involved in the 
storage and degradation of transcripts through the interactions with distinct proteins such 
as PABPs and decapping enzymes (Dcp1/Dcp2) [39]. TgHoDI's colocalization with 
PABPC3 at several areas throughout the cytoplasm suggests the involvement of TgHoDI 
in stress response. The incomplete colocalization of TgHoDI with either stress induced 
mRNA aggregates or PABPC3 may indicate another function within the cytoplasm (Fig. 
2.12). This gives rise to the possibility that TgHoDI functions similarly to Dhh1 in both 
the repression and degradation of transcripts.  
 To validate the participation of TgHoDI in the function of stress-induced RNA 
granules, cycloheximide and arsenite treatment was performed. Extracellular parasites 
subjected to cycloheximide treatment displayed a complete loss of TgHoDI aggregates in 
the cytoplasm (Fig. 2.14). These observations are in agreement with previous studies 
identifying the loss of the human Rck/p54 DEAD-box aggregates after cycloheximide 
treatment [77]. Interestingly, the localization of TgHoDI post-cycloheximide treatment is 
very similar to that observed for intracellular tachyzoite parasites (Fig. 2.11). This 
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observation, in combination with the maintained expression of TgHoDI, can be seen as 
an indication of multiple cellular functions. The ability of the same DEAD-box protein to 
be involved in various cellular functions has been observed for Dhh1 [58]. Dhh1 was 
initially determined to be involved in the decapping complex assembly, however recent 
studies have shown that it is also implicated in stress response and granules formation 
under glucose deprivation [39, 65]. Arsenite treatment of extracellular parasites increased 
the size and prevalence of TgHoDI aggregates within the cytoplasm (Fig. 2.14). Also, an 
increase in mRNA aggregate size and number is in agreement with previous studies 
analyzing stress response in extracellular parasites [75]. This increase is directly 
correlated to the oxidative stress induced by arsenite and therefore centers TgHoDI as a 
player in stress response.  
 The alterations in granule formation as the consequence of chemical treatments 
suggest TgHoDI is able to participate in translational repression during environmental 
stress. As shown in Figure 3.2 (lower illustration) the presence of distinct foci in 
untreated extracellular parasites is indicative of the shutdown of active translation and the 
formation of stress granules. Toxoplasma is an obligate intracellular organism incapable 
of surviving for extended periods outside of a host [1]. Also, the apparent dispersed 
localization of TgHoDI in intracellular parasite, which is similar to cycloheximide treated 
parasites, suggests the absence of translational repression with transcripts becoming 
incorporated into the polysome. Arsenite treatment has been shown to inhibit translation 
and induce the formation of stress granules. The exposure to arsenite causes a greater 
stress response, which lead to the increase in both TgHoDI and mRNA granule size and 
number. Together, these results suggest that TgHoDI participates in the formation of 
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stress granules when translation is arrested. However, it cannot be ruled out that TgHoDI 
may also functions in processing bodies. The presence of TgHoDI in intracellular 
tachyzoites and the incomplete colocalization with PABP in extracellular parasites 
suggests this second function of TgHoDI within the cytoplasm. Therefore, subsequent 
experiments must be performed to determine the involvement of TgHoDI in these 
granules.  
 The findings of this study strongly suggests the presence of a conserved post-
transcriptional mechanism in Toxoplasma involving TgHoDI. As shown in Figure 3.2 
(upper illustration), active translation can be halted by either environmental stress 
(extracellular parasites) or chemical treatment (arsenite) leading to the formation of stress 
granules. Also, treatments inducing the stalling of translation machinery (i.e. CHX) leads 
to the dissociation of stress granules and processing bodies by the trapping of mRNA in 
the polysome. Furthermore, the findings have shown that the composition of these 
aggregates are indicative of the fate of mRNA associated in them. This study is the first 
to characterize such a mechanism is Toxoplasma and provides the framework for future 
studies to identify the mechanisms involved in stress response and tachyzoite-bradyzoite 
differentiation. 
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Figure 3.2 Identified mechanism for post-transcriptional gene regulation in T. gondii 
 (Top) A general outline of the identified mechanism for post-transcriptional 
regulation of mRNA. mRNAs can be involved in either active translation (polysome), 
storage (stress granules) or degradation (processing bodies). Chemical treatments cause a 
shift of mRNA localization from one sub-cellular structure to another. The composition 
of these structures dictates the fate of mRNA involved. Double strike through indicates a 
lack of component present in the structure. (Bottom) Summary of IFA observations of 
this study. The localization of TgHoDI, which has been identified as a member in 
mechanisms of stress response, is altered in the different parasite strains and under the 
treatment of cycloheximide and arsenite.  
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 A hallmark experiment in the analysis of newly identified DEAD-box RNA 
helicases is to determine whether the protein is capable of complementing the TS
-
 growth 
defect of Δdhh1 cells. TgHoDI partially rescued yeast cell growth at 24 hours, validating 
its function in stress response. After 36 hours complementation appears to occur to a 
greater extent which may signify the necessity of increased incubation periods for full 
complementation to occur. However, the expression of TgHoDI from the strong GPD 
promoter exemplifies that TgHoDI is required at greater levels in comparison to Dhh1 to 
complement growth (Fig.2.15). The necessary increase in both incubation time and 
TgHoDI levels required for complete complementation may suggest that TgHoDI 
functions in a similar, but not identical, cellular stress response mechanism as Dhh1. 
Many proteins have been shown to function in stress-specific mechanisms, therefore 
there is a possibility that TgHoDI is incapable of fully functioning in temperature induced 
stress [81]. In addition, the variation in TgHoDI's ability to complement the TS
-
 
phenotype may be an indication of post-translational modifications, such as 
phosphorylation. The expression of TgHoDI, which has three possible phosphorylation 
sites, in yeast would influence the occurrence of these modifications leading to possible 
alterations in protein function. Similarly, TgHoDI may require Toxoplasma specific 
factors which may enable proper function to occur. Taken as a whole, TgHoDI has been 
implicated in post-transcriptional regulation during stress response as a functional 
analogue to Dhh1 in yeast.  
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CHAPTER IV 
Concluding Remarks and Future Directions 
 DEAD-box RNA helicases are highly conserved proteins which have been 
implicated in almost all aspects of RNA metabolism in organisms ranging from yeast to 
complex eukaryotes. However, in Toxoplasma gondii the function of these proteins have 
not yet been studied. Their implications in post-transcriptional gene regulation remains 
unknown. The study of DEAD-box RNA helicases may provide the information 
necessary to reveal how these mechanisms function in post-transcriptional regulation and 
translational repression.  
 The current study has provided significant insight into the involvement of 
TgHoDI in the regulation of mRNA during stress response. This findings show that 
TgHoDI is a component in stress granules and capable of functioning in a similar manner 
as the DEAD-box protein Dhh1 in yeast. TgHoDI localization is dynamic and reflects its 
possible participation in post-transcriptional gene regulation. This study strongly suggests 
the presence of conserved mechanisms regulating the availability of transcripts between 
translational machinery and sub-cellular structures (SGs and PBs). These mechanisms are 
vital in stress mediated repression of mRNA as well as tachyzoite-bradyzoite 
differentiation. Future work should be performed to determine how TgHoDI expression 
may affect the stress-induced response in Toxoplasma. It will be interesting to determine 
if the abolishment or over expression of TgHoDI protein will alter the ability of parasites 
to respond to cellular stress. Furthermore, these studies may have implications in the 
stage-specific repression of transcripts and therefore may shed light on the mechanisms 
behind tachyzoite-bradyzoite differentiation. For this to occur, it will be necessary to 
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determine the involvement of TgHoDI with specific mRNAs and therefore alterations in 
mRNA levels can be analyzed as a function of TgHoDI expression. In accordance with 
this, it will be vital to investigate the regulation of total mRNA populations at various 
levels of TgHoDI expression. The ability of TgHoDI to regulate mRNA in both the 
sexual and asexual parasitic life stages may further allow for the characterization of 
protein function. The homologue of TgHoDI in Plasmodium was determined to play a 
larger role in the sexual component of the parasitic life cycle which may suggest the 
involvement of TgHoDI in the sexual stage of Toxoplasma. 
 Other studies must be performed to determine if TgHoDI localization is altered as 
a function of various environmental stresses. It has been shown that the composition of 
cytosolic granules changes according to variable stress conditions. It will be necessary to 
determine the involvement of TgHoDI within these granules during stresses such as 
nutrient deprivation, temperature variations and several chemical treatments. This will 
clarify the function of TgHoDI as a central player in a universal mechanism of stress 
response or a stress-specific response. Furthermore, these colocalization studies must be 
performed with markers of not only stress granules, but also processing bodies (i.e. 
Dcp1a). The presence of TgHoDI during the various life stages and treatments in this 
study suggest a second function which may be implicated in p-body formation.  
 Moreover, in vitro studies analyzing the function of TgHoDI in RNA unwinding 
will validate its involvement in mRNP remodeling. However, prior to these studies it may 
be necessary to determine if post-translational protein modifications such as 
phosphorylation alter protein function.  
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CHAPTER V - METHODS 
* For materials, please see Appendix B.  
5.1 Plasmid construction 
pSF-TAP-LIC-HX-Dozi and pYFP-LIC-HX-Dozi 
 Standard protocol for ligation independent cloning was performed as previously 
described [82]. To produce clonal parasites with endogenous C-terminal tagging of the 
TgHoDI protein, a 2.8 Kb genomic sequence of TgHoDI (Toxodb gene ID # 
TggT1_089230; chrXI: 5,292-8,058) was PCR amplified from the ∆Ku80 genome using 
the oligonucleotide primers TgDozi.LIC.F and TgDozi.LIC.R (Appendix B). This 
product was T4 DNA polymerase treated to create a 15 base pair 5’ overhang by means 
of 3’to 5’ exonuclease activity. The pYFP-LIC-HX and pSF-TAP-LIC-HX vectors were 
linearized using PacI restriction endonuclease, T4 DNA polymerase treated and gel 
purified. The PCR fragment was cloned into the linearized vectors with the resultant 
plasmids transformed into E.coli cells and subjected to colony PCR using the 
TgDozi.LIC.F and TgDozi.LIC.R oligonucleotides. Plasmid confirmation was performed 
by EcoRI and PvuII restriction endonuclease analyses (see plasmid maps, Appendix C). 
HoDI-S-DD-F LIC-HX 
 To produce clonal parasites with endogenous C-terminal tagging of the TgHoDI 
protein with the ddFKBP, PCR analysis was performed to amplify the CDS of ddFKBP 
from pCAG-EGFpd2 plasmid using the oligonucleotide primers cf_FW_S_DD_F and 
cf_FW_S_DD_R (Appendix B). The plasmid expressing HoDI-SF (pSF-TAP-LIC-HX-
Dozi) was digested with SfoI which produced a single cut in between the streptavidin and 
FLAG tags. The ddFKBP product was then introduced into the linearized pSF-TAP-LIC-
HX-Dozi plasmid via the cold fusion method of cloning. This allowed for the CDS of 
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ddFKBP to be flanked by the Strep and FLAG tags. Plasmid confirmation was performed 
by ApaLI, PstI and PvuII restriction endonuclease analyses (see plasmid maps, Appendix 
C). 
pRS424-GPD_TgDozi plasmid 
 To place the expression of TgHoDI under the control of the glyceraldehyde-3-
phosphate dehydrogenase (GPD) promoter for complementation studies in S. cerevisiae, 
the open reading frame of TgHoDI was excised from the pET-28b_TgDozi expression 
plasmid by NcoI digestion followed by Klenow Fragment treatment to produce a 5’ blunt 
end. Linearized vector was then digested with XhoI and gel extracted. In the preparation 
of the pRS424-GPD plasmid the vector was digested with NcoI, phenol: chloroform 
extracted and digested with SmaI. The fragment was cloned into the linearized vector and 
the resultant pRS424-GPD_TgDozi plasmid was subjected to HincII and NdeI restriction 
endonuclease analyses.  
5.2 Cell and Parasite Culture 
Human Foreskin Fibroblasts 
 Human foreskin fibroblasts were maintained using Dulbecco's Modified Eagle 
Medium (DMEM) with 25 mM D-glucose and 4 mM L-glutamine supplemented with 
10% cosmic calf and 0.5x antibiotic-antimycotic at 37
o
C in 5% CO2. 
T. gondii 
 Two strains of T. gondii, RH∆HX and ∆Ku80, were cultured in confluent human 
foreskin fibroblasts (HFF) using Minimal Essential Media Eagle (MEM), supplemented 
with 1% dialyzed fetal bovine serum (dFBS) and 0.5x antibiotic-antimycotic.  
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 Transgenic parasites, TgHoDI-SF and TgHoDI-YFP, were cultured in MEM 
supplemented with 1% dFBS, 2.5x antibiotic-antimycotic, 25 mg/mL myocophenolic 
acid and 25 mg/mL xanthine. 
5.3 Transformation of microorganisms 
 E. coli 
 Standard protocol performed as previously described [83]. XL1-Blue competent 
cells were incubated with plasmid DNA on ice for 30 minutes. The cells were then heat 
shocked at 42
o
C for 45 seconds and incubated on ice for 2 minutes. Cells were then 
combined with 500 µL of Super Optimal Broth with catabolite-repression (SOC Medium) 
and incubated at 37
o
C for 1 hour with agitation. An appropriate amount of transformation 
mixtures was then plated on an Luria Bertani (LB) agar plate with appropriate antibiotic 
and grown at 37
o
C overnight. 
 T. gondii 
 Standard protocol performed as previously described [84]. Freshly lysed ∆Ku80 
parasites (~ 2 x 10
6
 parasites) were used for each transfection via electroporation using a 
BTX ECM 630 (1500 volts, 25 Ω, and 25 μF). For each transfection, 20 µg of expression 
plasmids encoding pSF-TAP-LIC-HX-TgDozi or pYFP-LIC-HX-TgDozi were linearized 
with PflmI and PmeI, respectively, mixed with harvested parasites in a 400 µL 
electroporation mixture and electroporated in a 4 mm-gap cuvette. Following 
electroporation, the parasites were cultured in confluent HFF monolayers grown using 
MEM with 1% dFBS and antibiotic-antimycotic at 37
o
C in 5% CO2. Transgenic parasites 
were then selected for with MEM supplemented with 1% dFBS, 0.5x antibiotic-
antimycotic, 25 mg/mL myocophenolic acid and 25 mg/mL xanthine. Clonal parasites 
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were then isolated by serial dilution in 96 well plates to obtain a clonal population [84]. 
Transgenic populations were confirmed by PCR and Western blot analysis. 
S. cerevisiae 
 Standard lithium acetate transformation protocol was performed as previously 
described [83]. Wild-type yeast and YTC444 were grown on YAPD and Leu
-
 synthetic 
drop-out plates, for the WT and YTC444 respectively, and colonies were selected and 
grown overnight at 30
o
C in YAPD media with agitation. YTC444 yeast was transformed 
with p414PromDhh1and pRS424-GPD_TgDozi, for expression of Dhh1 and TgHoDI, 
respectively. Salmon sperm DNA was incubated at 90
o
C for 3 minutes, quenched on ice 
for 2 minutes and combined with 500 µL of plate solution. The solution was then 
combined with yeast cells and ~1 µg of expression plasmid, mixed and incubated 
overnight at room temperature. Cell suspensions were then centrifuged at 2,000 rpm for 1 
minute and cells were re-suspended in 300 µL of 1x TE. An appropriate amount of 
transformation was then spread onto Leu
-
/Trp
-
 plates and incubated at 30
o
C for 2-4 days. 
5.4 Immunological detection methods 
Western Blot 
 Standard protocol as previously described [83]. Lysates of T. gondii parasites 
were prepared by addition of 50 µL of RIPA buffer, sonication for 5 seconds and 
incubation on ice. Protein concentration was measured using the RC DC Protein Assay 
according to manufacturer’s instructions (Bio-Rad Laboratories, Cat #500-0119) and 
absorbance values were taken at 750 nm on the Genesys 10 UV/Visible 
spectrophotometer. Lysates were denatured using 6x SDS protein loading dye and 
resolved on a 10% SDS-PAGE for 1 hour and subsequently transferred to a nitrocellulose 
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membrane. Following transfer, nitrocellulose blots were blocked with 5% (w/v) non-fat 
skim milk in TBST for a minimum of 30 minutes and incubated with primary antibodies 
in 2% (w/v) non-fat skim milk in TBST for 1 hour. The primary antibodies used were: 
mouse anti-Tub (1:5,000), mouse anti-FLAG (1:5,000), rabbit anti-LDH1 (1:2,000), and 
goat anti-GFP (1:2,500) (Appendix B). Blots were subsequently washed 3 times for 5 
minutes with TBST and incubated with specific secondary antibodies for 1 hour. The 
secondary antibodies used were: horseradish peroxidase (HRP)-goat anti-mouse 
(1:10,000), HRP-rabbit anti-goat (1:10,000), HRP-goat anti-rabbit (1:10,000). Finally, 
blots were washed, incubated with Chemiluminescent HRP Substrate Kit (Millipore) and 
visualized using the FluorChem Q Imager (Alpha Innotech) with AlphaView-FluorChem 
Q software. 
 Immunofluorescence Assay 
 HFF monolayers were cultured on coverslips until confluent, infected with ~1 x 
10
6
 freshly lysed parasites and incubated at 37
o
C and 5% CO2 for 24 hours. Cells were 
rinsed three times in 1x (v/v) phosphate buffer saline (PBS), fixed with 3% (w/v) 
paraformaldehyde for 5 minutes and permeabilized with 0.25% Triton X-100 in PBS for 
10 minutes. Coverslips were then washed in 1x PBS and subsequently incubated in a 
blocking solution of 5% (w/v) bovine serum albumin (BSA) in PBS with gentle agitation 
for 1 hour at room temperature. Coverslips were then incubated for 1 hour in a humidity 
chamber with a specific primary antibody diluted in 2% (w/v) BSA. The primary 
antibodies used were: mouse anti-FLAG (1:500) and rabbit anti-PABPC3 (1:500). Cells 
were once again washed in 1x PBS and incubated for 1 hour with secondary antibody 
diluted in 2% (w/v) BSA. The secondary antibodies used were: Rhodamine (Rho)-
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conjugated goat anti-rabbit (1:500) and Rho-conjugated goat anti-mouse (1:500). Cells 
were then stained with Hoechst stain (100 μM) at room temperature, washed twice with 
1x PBS and mounted on glass slides with fluoromount. Imaging was performed on a 
Leica DMI 6000B inverted fluorescent microscope using HCX PL Apo 100x/1.40-0.70 
objective and a Leica DFC 360FX camera in addition to the Leica Application Software 
(LAS). Confocal imaging was performed on an Olympus 1X81 inverted microscope 
using Plan Apo-N 60x/1.42 oil objective outfitted with Fluoview 1000 imagine system. 
Post-acquisition image processing was performed with Adobe Photoshop 7.0. 
 For extracellular T. gondii, ~ 1 x 10
6
 freshly lysed parasites were incubated on 
coverslips at 37
o
C and 5% CO2 and allowed to adhere for 1 hour. Coverslips were rinsed 
in 1x (v/v) PBS and fixed/permeabilized at 4°C with ice cold methanol for 10 minutes. 
The remaining protocol was as previously described. Fluorescence in situ Hybridization  
 Freshly lysed parasites (~ 1 x 10
6
) were transferred on coverslips at 37
o
C and 5% 
CO2 and allowed to adhere for 1 hour. Coverslips were washed 1x (v/v) PBS and 
fixed/permeabilized at 4°C with ice cold methanol for 10 minutes. Parasites were rinsed 
with 2x SSC buffer 2 times for 10 minutes and incubated with hybridization buffer, 
~400ng biotin labeled oligo-dT50 and deionized formamide in a humidity chamber 
overnight at 37
o
C. The coverslips were then washed 2 times with 2x SSC for 30 minutes 
and 1 time in 0.5X SSC for 15 minutes. Parasites were then incubated for 60 minutes at 
room temperature in Rho-conjugated streptavidin (1:500) in 4x SSC in a humidified 
chamber. Coverslips were then washed with 2 times with 4x SSC for 10 minutes and 1 
time in 4x SSC with 0.01% Triton X-100. Finally, coverslips were stained with Hoechst 
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stain (100 μM) at room temperature, washed twice with 4X SSC for 5 minutes and 
mounted on glass slides with fluoromount. 
5.5 Assays for functional analysis 
Drug treatment 
 For extracellular T. gondii, ~ 1 x 10
6
 freshly lysed parasites were incubated on 
coverslips at 37
o
C and 5% CO2 and allowed to adhere for 1 hour. Parasites were pre-
treated with either 50 µg/mL cycloheximide or 10 µM sodium m-arsenite. Subsequent 
IFA and FISH analysis were performed as previously stated. 
 S. cerevisiae ∆dhh1 Complementation and Growth 
 To determine the ability of TgHoDI to functionally complement the temperature 
dependence of the YTC444 yeast strain, transformed cells were grown in 4 mL of YAPD 
media and incubated overnight at 30
o
C with agitation. For the expression of Dhh1, cells 
were transformed with a low copy centromeric plasmid expressing Dhh1 from its 
endogenous promoter. For the expression of TgHoDI, cells were transformed with a high 
copy number plasmid (2µm) expressing TgHoDI under the strong yeast GPD promoter. 
The optical density (OD) was then taken at 600 nm to confirm cells were in the mid-log 
phase of growth. Cells were subsequently diluted to an OD of ~0.5. Serial dilutions were 
performed using sterile 1X TE and 3 µL of each dilution was spotted onto YPAD plates. 
Plates were then incubated upright at 30
o
C and 37
o
C for 2 days. 
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APPENDIX A 
Name of Gene Chr.  
Accession  
Number 
Molecular 
Weight 
DEAD/DEAH box helicase, putative 1a TGGT1_074650 273737 Da 
ATP-dependent helicase / DEAD, putative 1b TGGT1_020410 81975 Da 
DEAD/DEAH box helicase, putative II TGGT1_065970 139953 Da 
DEAD/DEAH box helicase, putative II TGGT1_053690 61270Da 
DEAD-box helicase family protein II TGGT1_096090 130939 Da 
DEAD/DEAH box helicase, putative IX TGGT1_053270 73199 Da 
DEAD/DEAH box helicase, putative IX TGGT1_041270 175200 Da 
DEAD/DEAH box helicase, putative V TGGT1_037060 145819 Da 
DEAD/DEAH box helicase, putative VI TGGT1_049520 156895 Da 
DEAD/DEAH box helicase, putative VI TGGT1_045960 111689 Da 
DEAD/DEAH box helicase, putative VIIb TGGT1_009750 172792 Da 
DEAD/DEAH box helicase, putative VIIb TGGT1_013850 202672 Da 
DEAD RNA helicase, putative X TGGT1_081240 130943 Da 
DEAD/DEAH box helicase, putative X TGGT1_077470 238791 Da 
DEAD/DEAH box helicase, putative X TGGT1_069190 59939 Da 
DEAD/DEAH box helicase, putative XI TGGT1_089630 74805 Da 
DEAD/DEAH box helicase, putative XI TGGT1_093990 103253 Da 
DEAD/DEAH box RNA helicase, putative XII TGGT1_030160 107394 Da 
ATP-dependent RNA helicase, putative 1b TGGT1_021570 107244 Da 
ATP-dependent RNA helicase, putative II TGGT1_065520 169171 Da 
helicase, putative VIIa TGGT1_016870 189156 Da 
ATP-dependent helicase, putaive, putative VIIb TGGT1_013990 45127 Da 
ATP-dependent RNA helicase, putative VIII TGGT1_109180 105362 Da 
ATP-dependent RNA helicase, putative X TGGT1_081400 78594 Da 
ATP-dependent RNA helicase, putative XI TGGT1_089210 63848 Da 
ATP-dependent RNA helicase, putative XI TGGT1_089230 53462 Da 
ATP-dependent RNA helicase, putative XI TGGT1_098270 49115 Da 
ATP-dependent RNA helicase, putative 1a TGGT1_075360 77076 Da 
ATP-dependent DNA helicase, putative Ib TGGT1_021870 115676 Da 
ATP-dependent RNA helicase, putative III TGGT1_002060 71697 Da 
Helicase, putative IV TGGT1_123390 115949 Da 
ATP-dependent RNA helicase, putative IX TGGT1_056640 99433 Da 
Helicase, putative IX TGGT1_075910 299694 Da 
ATP-dependent RNA helicase, putative 1a TGGT1_075360 77076 Da 
RNA helicase, putative IX TGGT1_031770 74705 Da 
RNA helicase, putative VIIa TGGT1_063370 116139 Da 
ATP-dependent RNA helicase, putative VIIb TGGT1_044400 88822 Da 
ATP-dependent RNA helicase, putative VIIb TGGT1_044050 116099 Da 
ATP-dependent DNA helicase, putative VIIb TGGT1_010560 98394 Da 
ATP-dependent RNA helicase, putative VIIb TGGT1_010590 97328 Da 
RNA helicase, putative VIII TGGT1_106360 43728 Da 
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ATP-dependent RNA helicase, putative X TGGT1_077510 174755 Da 
ATP-dependent RNA helicase, putative XII TGGT1_102880 121538 Da 
DEAH-box RNA/DNA helicase, putative IV TGGT1_122680 236964 Da 
DEAH-box RNA/DNA helicase, putative V TGGT1_035990 241922 Da 
 
Table A1 DEAD-box and ATP dependent RNA helicases in Toxoplasma 
 
 Bioinformatic analysis of Dead-box and ATP dependent RNA helicases in T. 
gondii using Toxodb Database [15]. Analyses identified 20 putative proteins with high 
sequence homology to the DEAD-box RNA helicases with another 26 possible ATP 
dependent RNA helicases. The chromosomal location, gene ID (in type I strain) and 
molecular weight are shown. 
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APPENDIX B 
Buffers and Solutions Composition 
 
Electroporation mixture 
120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4 
(pH 7.6), 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM 
glutathione. 
Radioimmunoprecipitation 
assay buffer (RIPA) 
25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% w/v Triton 
X-100, 1% w/v sodium deoxycholate and 0.1% w/v SDS 
 
6x SDS protein loading 
dye  
12% w/v SDS, 0.06% w/v bromophenol blue, 47% v/v 
glycerol, 6% v/v 1M Tris-pH 6.8 and 12.5% v/v β-
mercaptoethanol 
1x Tris-buffered saline 
with Tween-20 (TBST) 
68 mM NaCl, 8.3 mM Tris-base (pH 7.6) and 0.05% v/v 
Tween-20 
20x Saline-sodium citrate 
(SSC) 
17.5% w/v NaCl, 9% w/v sodium citrate 
 
Hybridization buffer  
25% v/v 20x SSC, 50% v/v 50% dextran sulfate, 25% v/v 
yeast tRNA 
 
Table B1 Buffers and their formula for various experiments in the study 
 
 The composition of buffers used in the study are shown with their corresponding 
composition. These buffers vary in their application from parasite transformation, protein 
lysate acquisition and FISH analyses. 
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Antibody Against Antisera 
Name 
Raised 
in 
Obtained From 
Alpha-Tubulin  α-Tub (12G10) Mouse E.M. Nelsen; DSHB 
D-tag (FLAG) α-FLAG Mouse Applied Biological Materials 
(ABM) Inc. (#G191) 
Poly-A Binding Protein 
C3 
α-PABPC3 Rabbit ABM Inc. (#Y058722)  
Green Fluorescent Protein  α-GFP Goat Rockland (#17549)  
 
Lactate Dehydrogenase-1 
 
α-LDH1 
 
Rabbit 
Dr. Stephen Parmley; Palo 
Alto Medical Foundation; 
Calif. 
 
Bradyzoite Antigen-1 
 
α-BAG1 
 
Mouse 
Dr. Louis Weiss, Albert 
Einstein College of Medicine, 
N.Y 
Horseradish peroxidase 
(HRP) anti-mouse  
HRP α-Mouse Goat Rockland (#19072) 
HRP anti-goat  HRP α-Goat Rabbit Rockland (#17320) 
HRP anti-rabbit  HRP α-Rabbit Goat Rockland (#15949) 
Rhodamine-conjugated 
(Rho) anti-rabbit  
Rho α-Rabbit Goat Rockland (#2495) 
Rho-conjugated anti-
mouse 
Rho α-Mouse Goat Rockland (#610-100-040) 
Rho-conjugated anti-goat  Rho α-Goat Donkey Rockland (#3212) 
Rho-conjugated 
streptavidin  
Rho α-Strep N/A Rockland (#22837) 
 
Table B2 Antisera  
 
 Throughout this study, antisera were utilized in immunodetection studies such as 
Western blot analysis, IFA and FISH. Antisera name, target protein and organism raised 
in are present. Also, the company and catalog numbers are presented. 
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Culture Material Composition Obtained From 
 
Dulbecco’s Modified 
Eagle Media (DMEM) 
Modifications. With: 25 mM glucose, 
4 mM L-glutamine and 0.0399 mM 
phenol red. Without: sodium 
pyruvate, HEPES and sodium 
bicarbonate. 
Invitrogen (#12100-
046) 
 
Antibiotic-Antimycotic  
(100x) 
10000 units/mL penicillin, 10000 
µg/mL streptomycin and 25 µg/mL 
amphotericin B. 
Invitrogen (#15240-
062) 
 
Minimum Essential Media 
Eagle (MEM) 
Modifications. With: 2 mM L-
glutamine and 0.0266 mM phenol red. 
Without: HEPES and sodium 
bicarbonate. 
Invitrogen 
(#61100061) 
Yeast Extract Peptone 
Dextrose with Adenine 
(YPAD) plate Solution 
2% w/v bacto peptone, 1% w/v yeast 
extract, 2% w/v D-glucose, 2% w/v 
bacto agar, 0.001% w/v adenine 
 
N/A 
 
Yeast Plate solution  
90% w/v of 45% polyethylene glycol, 
10% v/v 1M lithium acetate, 1% v/v 
Tris-HCl pH 7.5 and 0.2% v/v 0.5M 
EDTA 
 
N/A 
 
Super Optimal Broth with 
catabolite repression 
(SOC) 
2% w/v bacto-tryptone, 0.5% w/v 
bacto-yeast extract, 0.05% w/v NaCl, 
10 mM MgCl2, 2.5 mM KCl and 20 
mM glucose. 
 
N/A 
 
Luria-Burtani (LB) Agar 
plate Solution  
1% w/v bacto-tryptone, 0.5% w/v 
bacto-yeast, 1% w/v NaCl, 1 x 10
-4
 % 
w/v antibiotic and 1.5% w/v bacto-
agar 
N/A 
 
Table B3 Culture Material  
 
 Various culture materials were required for growth of various microorganisms 
used in the study. The name, composition and company (if applicable) are shown. 
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Miscellaneous Materials Obtained From 
Xanthine Sigma (#X-3627) 
Mycophenolic acid Bio Basic Inc. (#24280-93) 
Sodium m-Arsenite Sigma (C7784-46-5) 
Cycloheximide Sigma (C7698-1G) 
Cosmic Calf Serum (CCS) ThermoFisher Scientific; Hylcone (#H3008704N) 
Dialyzed Fetal Bovine serum 
(dFBS) 
ThermoFisher Scientific; Hyclone (#SH3007903) 
 
Table B4 Miscellaneous Materials for organism treatment 
 
 Material presented were used for the treatment of transgenic parasite clones as 
well as to maintain HFF monolayers. Material name and acquisition company are shown. 
   
 Parasite/Yeast Strains  Obtained From 
Human foreskin fibroblasts (HFF) ATCC (#1041) 
RH∆HX, T. gondii type I strain NIH AIDS Research and Reference Reagent 
Program, #2857 
∆Ku80 T. gondii Dr. Vernon B. Carruthers, University of 
Michigan, U.S.A 
Wild-type yeast strain (MATa ade2-
1, ura3-1, trp1-1, his3-11, leu2-3,112 
can1-100) 
Dr. Tien-Hsien Chang; Genomics Research 
Center, Academia Sinica, China. 
YTC444 strain (MATa dhh1∆::LEU2 
ade2-1, ura3-1, trp1-1, his3-11, leu2-
3,112 can1-100) 
Dr. Tien-Hsien Chang; Genomics Research 
Center, Academia Sinica, China. 
 
Table B5 Organisms used in study 
 
 Organisms used in the study are shown with their corresponding place of 
acquisition. For purchased materials, the corresponding lot number is given. 
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Parasite/Yeast Expression 
Vectors 
Obtained From 
pYFP-LIC-HX  Dr. Vernon B. Carruthers, Univ. of Michigan, 
U.S.A 
pSF-TAP-LIC-HX  Dr. Vernon B. Carruthers, Univ. of Michigan, 
U.S.A 
p414PromDhh1  Dr. Juana Diez, Universitat Pompeu Fabra, Spain 
pRS424-GPD Dr. Elizabeth Craig, Univ. of Wisconsin, U.S.A 
pCAG-EGFpd2 Dr. Markus Meissner, Univ. of Glasgow, Scotland 
pSF-TAP-LIC-HX-TgDozi  
Constructed for this study pYFP-LIC-HX-TgDozi 
pRS424-GPD_TgDozi 
pS-DD-F-LIC-HX-TgDoZI 
 
Table B6 Parental plasmids and constructs  
 
 The various vectors, both parental constructs for this study, are shown with their 
corresponding place of acquisition.  
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Oligonucleotide Name Sequence 
TgDozi.LIC.F (a) 5’-TACTTCCAATCCAATTTAATG 
 CTACGACGTGAATTG TTGATGG-3’ 
TgDozi.LIC.R (a') 5’-TCCTCCACTTCCAATTTTAGC 
GTAAATTGCTTCGTCAA TCTGG-3’ 
TgDozi_Validate_Fw (b) 5’-CTCAGCAGCGCATGCAACAC-3’ 
TgDozi_Validate_Rv (b') 5’-TGCGGATGAGACCAAGAACC-3’ 
pEGFP-N1 (c) 5'-GCCGTCCAGCTCGACCAG-3' 
cf_Dozi_Fw_pET28 5’-GTGCCGCGCGGCAGCCAT 
ATGAGCGCAGCCTACTACACC-3’ 
cf_Dozi_Rv_pET28 5’- GTGGTGGTGGTGGTGCTC 
GAGTGTGTAAATTGCTTCGTC-3’ 
cf_FW_S_DD_F 5'-CCGCAATTCGAAAAGGGC 
GCCGGAGTGCAGGTGGAAACC-3' 
cf_RV_S_DD_R 5'-GTAATCCTCACCAGAGGC 
GCCTTCCGGTTTTAGAAGCTC-3' 
dT-Fish 5'-/5Biosg/ T(x50) 
 
Table B7 Oligonucleotides used in the study 
 
 The complete list of oligonucleotides, and their corresponding sequences, which 
were used in this study are shown. All oligonucleotides were purchased from Integrated 
DNA Technologies, Inc. (IDT), Coralville, Iowa, U.S.A. 
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APPENDIX C 
 
 
 
Figure C1 Illustration of genomic TgHoDI sequence for creation of expression 
plasmids 
 An illustration of the genomic sequence of TgHoDI (orange) was acquired using 
the VNTI software V.10.3.0 (Invitrogen). This was used to assist in the cloning of 
subsequent expression plasmids for the endogenous tagging of TgHoDI protein. The 
location of oligonucleotide binding sites for the LIC forward and reverse primers are 
shown. Also, the binding sites of the validation oligonucleotides used for the 
confirmation of transgenic clones is shown. 
 
 
 
 
 
 
 
 
 
 
TGGT1 089230 HoDI 583.m00676
6028 bp
Last codon of CDSFirst codon of CDS
HoDI Genomic Sequence
Rv LIC primer
TgDozi Validate RvFw  LIC primer
TgDozi Validate Fw
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Figure C2 Illustration of TgHoDI-SF transgenic plasmid 
 An illustration of the expression plasmid for transgenic TgHoDI-SF clones. The 
genomic sequence fragment of TgHoDI (orange) was acquired by PCR analysis using the 
TgDozi.LIC.F (sense) and TgDozi.LIC.Rv (antisense) oligonucleotides. The location of 
streptavidin and FLAG tags are shown. Also, the hypoxanthine-xanthine-guanine 
phosphoribosyl transferase (HX) cassette, which is used for transgenic parasite selection, 
is shown (green). 
 
 
 
 
HoDI-SF TAP-LIC-HX
8541 bp
HoDI LIC-Genomic Fragment
univ ersal
FLAG tag
Strep tag
HX cassette
ANTISENSE PRM
SENSE PRM
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Figure C3 Illustration of TgHoDI-YFP transgenic plasmid 
 An illustration of the expression plasmid for transgenic TgHoDI-YFP clones. The 
genomic sequence fragment of TgHoDI (orange) was acquired by PCR analysis using the 
TgDozi.LIC.F (sense) and TgDozi.LIC.Rv (antisense) oligonucleotides. The location of 
coding sequence for the YFP tag is also shown (orange). The hypoxanthine-xanthine-
guanine phosphoribosyl transferase (HX) cassette, which is used for transgenic parasite 
selection, is shown (green). 
HoDI-YFP LIC HX
9135 bp
YFP
HoDI LIC-Genomic Fragment
HX Cassette
ANTISENSE PRM
SENSE PRM
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Figure C4 Illustration of TgHoDI-S-DD-F transgenic plasmid 
 An illustration of the expression plasmid for transgenic TgHoDI-S-DD-F clones 
for knockdown studies. The coding sequence for Strep-ddFKBP-FLAG was acquired by 
PCR amplification of pCAG-EGFpd2 vector using the cf_FW_S_DD_F and 
cf_FW_S_DD_R oligonucleotides. The TgHoDI-SF-TAP.LIC plasmid was linearized by 
SfoI endonuclease which resulted in a single cut in between the streptavidin and FLAG 
tags. The amplified ddFKBP CDS was then integrated into the linearized vector via cold 
fusion. The hypoxanthine-xanthine-guanine phosphoribosyl transferase (HX) cassette, 
which is used for transgenic parasite selection, is shown (green). 
 
 
 
 
 
 
 
HoDI-S-DD-F-TAP-LIC-HX
8868 bp
HoDI Genomic Fragment
ddFKBP
HX cassette
Strep tag
FLAG tag
univ ersal
Linker
SENSE PRM
ANTISENSE PRM
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